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1 Introduction  
 
The heart is the center and the driving force of the circulation of human blood. In a 
healthy body, it supplies all organs with blood by contracting in a regular rhythm. 
The human heart is divided into two parts. The left side, providing the oxygenated 
blood to the body, and the right side, pumping the venous body blood to the lungs 
for oxygenation. The systemic circulation driven by the left heart and the pulmonary 
circulation by the right heart, are normally connected in series. Thus, both 
circulations have their own muscular pump to push the blood through the vessels. 
Many malformations result in just one single proper working ventricle that supplies 
both circulations with a mixture of arterial and venous blood. In these cases, one 
ventricle has to work for both sides, providing the blood for both circulations, which 
are now placed in parallel. This leads to an overloading of the single ventricle. If no 
obstruction is present in the outflow tracts to the two circulations, and because of 
the low pulmonary vascular resistance, this leads to an increasing blood flow 
through the lungs, which causes symptoms of heart failure and later on of 
pulmonary hypertension. In patients with pulmonary outflow obstruction, the main 
problem is cyanosis, which results from the pulmonary blood flow being low and 
from the mixture of arterial and venous blood having low oxygen saturation. In 
patients with single ventricle and obstruction in the systemic outflow tract, the 
dominant symptoms are associated with low cardiac output in the systemic 
circulation and is manifest usually very early in life.  
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In order to protect patients from these damages, researchers have attempted to 
separate the two circulations and to place them back in series.  
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1.1 History 
	  
1.1.1 Development of the “Fontan-circulation” idea 
	  
In the beginning of the 1950s, the idea of a cavo-pulmonary shunt arose when 
researchers tried to find a means of creating a proper functioning circulation without 
the presence of the right ventricle. The aim was to bypass the right ventricle by 
taking advantage of the natural changes of the intrathoracic pressure with 
respiration. Although Glenn and Patino gave their names to the cavo-pulmonary 
bypass operation, “William Glenn was not the first to introduce the concept of cavo-
pulmonary anastomosis. He reported neither the first experimental study, nor the 
first clinically successful operation” [1]. Carlo A. Carlon and colleagues first 
described their experimental study of cavo-pulmonary shunt in dogs in 1950 [2]. The 
initial attempts were carried out in animal experiments and later on in humans. The 
strategy was to connect the proximal end of the divided azygos vein to the right 
pulmonary artery end to end and to make a preatrial ligation of the superior caval 
vein. Carlon's group soon realized that this passive mechanism was totally sufficient 
to carry deoxygenated blood through the lungs. Nevertheless, more than ten years 
passed before Carlon reported their first clinical experiences in 1964. Unfortunately, 
his first clinical reports appeared in journals rarely read by surgeons in those days, 
and so Carlo Carlon was quickly forgotten [1, 3].  
Several other surgeons tried to connect systemic venous vessels directly to the 
pulmonary arteries and to bypass the right ventricle, but without knowing about each 
other's work. In the early 1950s, many experimental studies of the vena cava-to-
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pulmonary artery anastomoses took place in various countries. In the USA, in 1954, 
William Glenn and Jose Patino reported their study on dogs who had undergone a 
superior vena cava-to-right pulmonary artery shunt by using the azygos vein in a 
similar technique to that of Carlon and colleagues [4]. In the same year, Francis 
Robicsek et al. reported their first experimental results of a direct vena cava-to-
pulmonary artery shunt in Budapest [5]. Harris B. Shumacker also performed 
experimental direct cavo-pulmonary shunts in the USA [6]. In Russia, Nikolai K. 
Galankin and Tigran M. Darbinian first brought up the idea of a direct cavo-
pulmonary anastomosis [7]. Shumacker performed the first clinical attempts in 1954 
[6]. Even though unsuccessful, this was the courageous first step. Some years later, 
Evgenii N. Meshalkin reported the first clinical success of a direct cavo-pulmonary 
anastomosis (superior caval vein to right pulmonary artery "end-to-end") [8]. In 
1958, this achievement was followed by Glenn [9] and later on by Rasmusen [10] 
and Robicsek [11].  
The person who actually deserves to be called the first surgeon who successfully 
undertook an anastomosis of the superior caval vein to the pulmonary artery is 
difficult to determine.  Even if retrospectively William Glenn was not the very first, it 
was this “extensive study undertaken by the Yale University Group and Glenn’s 
publications in the most-read surgical journals that finally convinced the world” [1].  
Subsequently, several surgeons tried to connect the inferior caval blood flow in 
addition to the superior caval blood flow to the pulmonary circulation. In 1954, John 
Rose et al. anastomosed both caval veins at the same time to the main pulmonary 
artery [12], as did Jose Patino et al. in the same year. However, all these attempts 
were abortive. The researchers concluded that an inferior caval to pulmonary artery 
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anastomosis unavoidably leads to venous congestion in the splanchic system and 
consequently to death [13]. This assumption was only disproved after some time 
had passed and once the surgeons had understood that it was a problem with the 
adaptation of the circulation and the single ventricle.  
In 1960, Francis Robicsek et al. preformed a series of experiments in which they 
totally bypassed the right heart with success [14-16]. However, the inferior caval 
blood was not directed to the lung but to the left atrium, and no real clinical 
application was suitable for this operation. Nevertheless, retrospectively, this 
experience was hugely valuable to Francis Fontan and the idea that he had had with 
regard to this problem.  
 
1.1.2  The original Fontan operation 
 
The first time that a so-called “Fontan operation” was performed was in 1968; this 
was described in 1971 by Francis Fontan and Eugene Baudet [17].  
Their surgical method included a classic Glenn anastomosis (superior caval vein to 
the right pulmonary artery "end-to-end") followed by an anastomosis of the right 
atrial appendage to the proximal left pulmonary artery and closure of any interatrial 
communication. In addition, valved homografts were placed in the entry of the 
inferior vena cava to the right atrium and at the connection of the right atrial 
appendage to the left pulmonary artery (Figure 1).  
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Initially, the Fontan operation (FO) was meant to cure only patients with tricuspid 
atresia. However, later on, it was used as a surgical repair for nearly all forms of 
single ventricle. 
	  
	  
Figure 1: Atriopulmonary connection described by Francis Fontan and Eugene Baudet: 
connection of the right atrial appendage to the left pulmonary artery after a classic Glenn’s 
anastomosis (superior caval vein to right pulmonary artery "end-to-end"). [17] (PA – pulmonary 
artery, RA – right atrium, RPA – right pulmonary artery, VCI – vena cava inferior, VCS – vena 
cava superior). 
	  
	  
	  
In 1973, Guillermo Kreutzer et al. published a simplified operation technique, which 
was undertaken for the first time in 1970. Kreutzer connected the right atrium to the 
pulmonary artery by using an autologous pulmonary valve as a conduit. Neither a 
Glenn’s anastomosis with a transection of the right pulmonary artery, nor an 
interposition of a valve in the VCI was required in this operation [18] (Figure 2). 
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Other modifications followed. V.O. Björk et al. described a direct anastomosis of the 
right atrium to the right ventricular outflow tract in 1979 [19], whereas R.F. Lins et al. 
performed a direct atriopulmonary anastomosis [20]. 
	  
	  
	  
	  
 
	  
	  
Figure 2: Atriopulmonary connection described by Guillermo Kreutzer: the pulmonary valve as 
an autologous connection between the right atrium and the pulmonary artery [18]. 
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1.1.3 Modifications of the Fontan operation 
1.1.3.1  Total cavopulmonary connections – TCPC 
	  
The earliest types of FO, the so-called atriopulmonary connections (APC), involved 
the use of the right atrium and its pumping function as the driving force for the 
pulmonary circulation. However, the question was soon raised as to whether the 
atrial pumping function is really effective for this circuit, and the idea of a total 
cavopulmonary connection emerged. The exclusion of the right atrium was expected 
to have a beneficial effect on the outcome after the Fontan procedure, especially 
with regard to the incidence of atrial arrhythmias. Various authors who compared 
the original APC to the TCPC provided evidence for this assumption [21]. 
 
1.1.3.1.1 Lateral tunnel - LT 
In 1987, Mark R. de Leval carried out the first total cavopulmonary connection 
(TCPC) [22]. Following the Glenn anastomosis, a TCPC was performed by 
connecting the inferior vena cava to the pulmonary artery by a tunnel in the lateral 
part of the right atrium. 
The benefit of this operation technique is that most of the right atrial chamber 
remains a low pressure system and is not distended thereby reducing the risk of 
early or late arrhythmias. Moreover, the turbulent flow in the atrium is minimized, 
which reduces energy losses and the risk of atrial thrombosis.  
 
	  
	  
13 
1.1.3.1.2  Extracardiac conduit – EC 
Even though superior to the original APC, the LT Fontan repair still has potential risk 
factors influencing the outcome. Aortic cross-clamping and cardioplegic cardiac 
arrest are still required. Atriotomy with long sutures lines remains necessary and 
causes extensive scar tissue with proarrhythmogenic potential. Therefore, a new 
method of total cavopulmonary anastomosis was suggested. The first attempts 
remained without success, but in 1990, Carlo Marcelletti et al. reported their first 
effective EC FO [23]. This modification of the Fontan procedure is today the method 
of choice in most of centers.  
Following the bidirectional Glenn anastomosis, the vena cava inferior is connected 
to the confluent pulmonary artery system by an EC, usually made of 
polytetrafluorethylen (PTFE, Gore-Tex). Because of the reduced manipulation and 
shorter atrial suture lines, this method is assumed to cause fewer sinus node 
dysfunctions and atrial tachyarrhythmias. By keeping a constant low pressure to the 
right atrium, no dilation occurs, which also minimizes the risk for arrhythmia.  
	  
	  
1.1.3.2  Fenestration 
	  
In both palliation types, a so-called fenestration can be created. Nancy Bridges 
advocated this modification of the Fontan procedure; it involves a connection 
between the pulmonary and systemic circulations [24]. If the resistance of the 
pulmonary circulation is elevated or the compliance of the single ventricle is 
reduced, a small amount of venous blood can directly leak into the systemic 
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circulation thereby increasing the cardiac output at the expense of mild systemic 
desaturation [25, 26].  
To create a fenestration, a 3- to 4-mm large hole is cut out of the LT or an 
anastomosis between the EC and the atrium is built. 
In high-risk patients, this technique effectively increases the rate of survival.  
Because of the risk of a paradoxical embolism after the adaptation phase, the 
fenestration can be closed, operatively or interventionally, during cardiac 
catheterization.  
	  
1.2 Selection criteria and indications for Fontan 
operation 
 
1.2.1 Selection criteria 
The initial criteria for patients with tricuspid atresia being selected for FO were set 
by Choussat and his colleagues in 1977 and were extremely strict. 
The original selection criteria were as follows: 
1. Minimum age of 4 years 
2. Sinus rhythm 
3. Normal caval drainage 
4. Right atrium of normal volume 
5. Mean pulmonary artery pressure ≤ 15 mmHg 
6. Pulmonary arterial resistance < 4U/m2 
7. Pulmonary artery to aorta diameter ratio ≥ 0.75 
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8. Normal ventricular function (ejection fraction > 0.6) 
9. Competent atrioventricular valve 
10. Absence of pulmonary artery distortion  
 
During the course of the constant modification of the operation technique over the 
last few decades, the selection criteria have also been refined. The question of age 
is more open, preoperative sinus rhythm is not imperative, and caval drainage and 
the volume of the right atrium are disregarded.  
However, even if more open today, certain guidelines remain. Cardiac requirements 
include unobstructed ventricular inflow without significant regurgitation, an adequate 
single ventricular function, and unobstructed outflow to the systemic circulation (no 
subaortic stenosis, no arterial hypertension, no aortic coarctation). These aspects 
are important as ventricular dysfunction and insufficiency of the atrioventricular 
valve may increase pulmonary pressure and impair prognosis. The conditions of the 
pulmonary part itself are: a non-restrictive connection between the superior caval 
vein and pulmonary arteries, good sized pulmonary arteries without distortion, a well 
developed pulmonary vascular bed, normal pulmonary vascular resistance, and 
unobstructed pulmonary venous return [27]. Nowadays, many of the cardiac 
requirements can be achieved by additional surgical or cardiological interventions.  
A regular rhythm is also extremely important for a functioning Fontan circulation. 
Continuous blood flow driven by a regularly contracting muscle is necessary to keep 
a stable hemodynamic in the circulation. 
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1.2.2  Indications  
The first FO were performed to cure patients with tricuspid atresia. Not only has the 
original operation been modified, but also the indications have greatly changed. 
Today, Fontan reconstruction is applied in all forms of functional single ventricle 
malformation and in complex congenital malformations for which no biventricular 
correction is possible.  
1.2.3  Single ventricle anatomy  
	  
Single ventricle malformation is caused by the deficient embryological development 
of the one of the ventricles. The looping of the primitive cardiac tube is followed by 
septation of the primitive ventricle and the formation of a common AV canal from 
endocardial cushion tissue. The poor alignment of this common AV valve with the 
ventricles may be one of the main reasons for single ventricle anatomy. Another 
source for functional single ventricle is an incomplete septation of the ventricular 
chambers and primary pulmonary or aortic valve disease. 
Depending on the morphological aspects of the dominant ventricle, two main forms 
of single ventricle are distinguished: single right ventricle and single left ventricle. 
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1.2.4  Subtypes of single ventricle 
1.2.4.1  SV of the left ventricular morphology  
1.2.4.1.1  Hypoplastic right heart syndrome (HRHS) 
The structures of the right heart, including the right ventricle, tricuspid valve, 
pulmonary valve, and pulmonary artery, are hypoplastic or even undeveloped. As a 
result, the neonate suffers from severe cyanosis because of inadequate pulmonary 
blood flow. Sometimes, perfusion of the coronary arteries, because of coronary 
fistulas is also a problem and causes ischemic damage of the heart muscle. In the 
form with pulmonary atresia, the pulmonary circulation is totally dependent on a 
ductus arteriosus Botalli or major aortopulmonary collateral arteries (MAPCAs).  
1.2.4.1.2  Tricuspid atresia  
This involves complete failure of the development of the tricuspid valve. Instead of 
the valve, an impermeable membrane or muscular tissue closes the inflow to the 
right ventricle. In most of the cases, a ventricular septal defect (VSD) exists. An 
atrial septal defect or patent foramen ovale is present, which guides the caval blood 
from the right atrium to the left one, where venous and arterial blood is mixed. 
Therefore, patients suffer from cyanosis. In addition, a pulmonary stenosis or even 
atresia might exist, which limits the pulmonary flow. If not, the high pumping 
pressure of the left ventricle may cause pulmonary hypertension.  
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1.2.4.1.3  Double inlet left ventricle (DILV) 
Both atria communicate with the single left ventricle by two atrioventricular valves. If 
no additional pulmonary stenosis is present, an enormous left-to-right shunt leads to 
a quick development of pulmonary hypertension. The double inlet type of single 
ventricle is more frequent associated with left ventricle morphology.  
1.2.4.1.4  Double outlet left ventricle (DOLV) 
DOLV is a very rare cardiac malformation in which both the aorta and the pulmonary 
artery arise, either exclusively or predominantly, from the left ventricle. 
	  
	  
1.2.4.2  SV of the right ventricular morphology  
1.2.4.2.1  Hypoplastic left heart syndrome (HLHS) 
This malformation is characterized by a hypoplastic or even absent left ventricle and 
stenosis or atresia of the aortic valve and of the mitral valve. The aorta ascendens 
and aortic arch is usually also hypoplastic. This leads to severe pulmonary 
overcirculation and inadequate systemic perfusion. The systemic circulation is totally 
dependent on a ductus arteriosus Botalli. 
1.2.4.2.2  Double outlet right ventricle (DORV) 
The pulmonary artery and the aorta arise entirely or predominantly from the right 
ventricle. The VSD is almost always present and is the only exit from the left 
ventricle. The double outlet right ventricle with a hypoplastic left ventricle or with a 
ventricular septal defect that is remote from the great arteries is not suitable for 
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biventricular repair and is one of the common forms of the functionally single 
ventricle.  
1.3 Arrhythmia as one of the complications 
after Fontan operation 
 
Even though nowadays, the early and late survival rates are as high as 95-97% [28], 
many early-, mid-, and long-term problems occur in patients with Fontan circulation. 
One of the most important problems is arrhythmia with the possible risk of low 
cardiac output, stroke, or pulmonary embolism, ultimately leading to “failing Fontan”. 
Arrhythmias can occur during or directly after the operation, but also a long time 
after the surgical intervention. A proper rhythm of the heart is necessary for a 
hemodynamically efficient circulation.  
Generally, in patients with congenital heart defects (CHD), rhythm irregularity 
increases morbidity [29] and mortality [30]. Long-lasting volume overload and high 
atrial pressure are the common reasons for the development of abnormal heart 
rhythm in this group of patients [17, 31, 32]. In addition to the surgical suture lines, 
the anatomic conduction barriers may generate arrhythmias [33]. However, the 
myocardium itself in patients with congenital heart defects may also be a substrate 
of rhythm problems [34]. 
	  
	  
1.3.1 Risk factors for arrhythmias after Fontan operation 
Surgical manipulations in the atrial myocardium are one of the main reasons for the 
development of arrhythmias. The substrate for arrhythmia can be the scar tissue in 
	  
	  
20 
the suture lines of a cavopulmonary anastomosis or a LT. The anatomic conduction 
barriers, i.e., the orifices of the inferior and superior vena cavae, the ostium of the 
coronary sinus, and the atrial septal defect, can also slow atrial conduction, possibly 
resulting in re-entry phenomena. The next risk factor is abnormal hemodynamics, 
which leads to dilation with fibrosis of the right atrium and may cause sinus node 
dysfunction. All these factors cause irregular atrial rhythm and are triggers for the 
onset of tachycardia [35].  
Electron-microscopic analysis has revealed that, in patients with tricuspid atresia, a 
congenitally abnormal atrial fiber array exists [34] that may cause tachycardia by 
slowing conduction. Almost 40% of patients with tricuspid atresia who have never 
undergone any surgery develop tachycardia by the forth decade of life [36, 37]. 
By totally bypassing the heart and thus reducing the length of the atrial suture lines, 
the EC FO is theoretically considered to be superior to the other forms of Fontan 
completion with regard to the development of arrhythmias.  
Other factors increasing the risk for the development of rhythm disturbances are an 
“older age at the time of initial repair, early postoperative arrhythmias, sinus node 
dysfunction, and double-inlet left ventricle” [21, 35, 38-40]. 
	  
	  
1.3.2 Forms of arrhythmia 
Arrhythmia includes all forms of heart rhythm that are abnormal in terms of 
frequency, regularity, and impulse generation. Whereas the normal impulse 
generator is the sinus node, adequate frequency is age-dependent.  
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The most common way to define the different forms of arrhythmia is by frequency: 
bradycardia and tachycardia.  
1.3.2.1 Tachycardia 
 
Tachycardia refers to an abnormally fast resting heart rate and can be subdivided in 
supraventricular (SVT) and ventricular (VT) tachycardia.  
1.3.2.1.1 Supraventricular tachycardia (SVT) 
In SVT, the trigger originates from a point above the bundle of His and leads to a 
rhythm higher than the age norm. An SVT of duration longer than 30s is called 
sustained SVT, whereas an SVT lasting less than 30s is a non-sustained SVT.  
The ECG shows a narrow QRS complex. Various forms of SVT have been 
observed.  
Generally the most frequent SVT is a sinus nodal tachycardia, which is usually 
physiological. A higher than age norm heart frequency with a normal sinus rhythm, 
caused by an appropriate stimulus is termed physiological.  
The sinoatrial node re-entrant tachycardia (SANTR) is caused by a	   re-entrant 
pathway localized within the sinoatrial (SA) node and perinodal tissue resulting in 
normal P-waves followed by an also normally configured QRS complex and is 
therefore difficult to distinguish from a sinus nodal tachycardia. Only the abrupt 
onset and termination of the arrhythmia aids clinically in differentiating these two 
types.  
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Another form of supraventricular tachycardia is an atrial ectopic tachycardia (AET) in 
which a single focus generates an abnormal P-wave followed by a regular narrow 
QRS complex, but the PR interval may be inappropriately long relative to the atrial 
rate. AET occurs because of an area of enhanced automaticity in the atrium, has a 
variable rate, and is influenced by the autonomic nervous system.  
In multifocal atrial tachycardia, at least 3 different foci in the atria are involved that 
cause 3 different configured P-waves followed by irregular narrow QRS complexes. 
Special forms of atrial tachycardia are atrial fibrillation (AF) caused by multiple 
simultaneous atrial re-entry loops (with rapid ventricular response, fibrillatory P-
waves that sometimes lead to a ventricular response with irregular narrow QRS 
complexes) and atrial flutter (AFL) (with rapid ventricular response, caused by an 
intra-atrial re-entry with atrial beats around 300bpm, which are conducted to the 
ventricle 4:1 – 2:1, rarely 1:1). 
Junctional ectopic tachycardia (JET) is caused by increased atrioventricular (AV) 
node automaticity leading to abnormal configured P-waves, which occur anywhere 
without relation to the regular narrow QRS complexes. Special forms of JET are the 
atrioventricular nodal re-entrant tachycardia (AVNRT) and atrioventricular 
reciprocating tachycardia (AVRT). 
AVNRT is generated by a re-entry circuit within or just next to the AV node and often 
consists of two small pathways, one faster than the other. With the AV node directly 
between the atrium and the ventricle, it often stimulates in both directions and leads 
to a retrogradely conducted P-wave buried under or just occurring behind the 
regular narrow QRS complex.   
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Atrioventricular reciprocating tachycardia results from a re-entry circuit and is larger 
than in AVNRT. AVRT is caused by an accessory pathway in the conduction system 
between the atria and ventricles (often a muscular structure). A common syndrome 
caused by an accessory pathway (bundle of Kent) crossing the AV valvular ring is 
the Wolff-Parkinson-White syndrome. The re-entry mechanism might be 
orthodromic (the AV node conducts down to the ventricle, and the accessory 
pathway leads to a retrogradly conducted P-wave just after the regular narrow QRS 
complex) or antidromic (the accessory pathway conducts down to the ventricle and 
the impulse re-enters the atrium via the AV node). Because initially not passing the 
bundle of His on the way to the ventricle, the QRS complex is often wider than 
usual, with a delta wave). 
In patients with SVT, the pulse is sometimes very fast, and as a hemodynamic 
result, patients might suffer from dizziness, syncope, dyspnea, angina pectoris, or 
even a cardiac shock. However, most of the time, SVT is self-limiting and patients 
do not even realize it. When present for a longer period, SVT might cause 
cardiomyopathy and therefore needs to be treated. Adenosine can acutely stop the 
tachycardia as it transiently blocks the AV node. If SVT persists, prophylactic 
medication, e.g., beta-blockers or even catheter ablation might be required. 
1.3.2.1.2  Ventricular tachycardia 
Ventricular tachycardia however is life threatening. The morphology of the QRS 
complexes distinguishes monomorphic VT (all QRS complexes appear to be 
uniform and originate from the same impulse generator in the ventricle) from 
polymorphic VT (differently shaped QRS complexes generated by different points in 
	  
	  
24 
the ventricle). Furthermore, VT may be continuous (>30s) or non-continuous (<30s). 
The symptoms of VT depend on the presence of an adequate cardiac output. If this 
is still possible, VT might even be asymptomatic, however only for a short time. 
Sooner or later, VT results in pulseless electrical activity or ventricular fibrillation.  
Ventricular tachycardia always requires treatment. In low frequency VT, 
cardioversion is the method of choice, and the electric shock application should be 
ECG controlled and performed during the non-vulnerable phase. If the patient is 
already unconscious or the ECG shows ventricular fibrillation, non-ECG controlled 
defibrillation is absolutely vital. If defibrillation is not available or fails, anti-arrhythmic 
medication, e.g., lidocaine or amiodarone is the second choice. If symptoms recur, a 
cardioverter-defibrillator has to be implanted.  
1.3.2.2  Bradycardia 
	  
Bradycardia is an abnormally slow resting heart rate. One reason for bradycardia is 
a reduced sinus node frequency caused either physiologically (e.g., in athletes) or  
by hypothyroidism, hypothermia, elevated vagal tone, or sick-sinus syndrome. 
Another reason can be a dysfunction of the conduction system, e.g., atrioventricular 
block or bradyarrhythmia absoluta caused by atrial fibrillation.  
Atrioventricular block is slowed or non-existing conduction from the atrium to the 
ventricle. There are three subtypes: 
- first degree AV block: delayed atrioventricular conduction with a prolonged PQ 
time 
- second degree AV block: Type 1 (Mobitz 1, Wenckebach) – continuously 
prolonged conduction with finally one total AV Block and Type 2 (Mobitz 2, Hay) – 
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intermittently non-conducted P waves not preceded by PR prolongation and not 
followed by PR shortening, usually with a fixed number of non-conducted P waves 
for every successfully conducted QRS complex.  
- third degree AV block (total AV block): no atrioventricular conduction, no 
connection between P-wave and QRS complex. 
Sick-sinus syndrome (sinus node disease, sinus node dysfunction) is the name for a 
group of arrhythmias in which the sinus node does not work properly. It is a rare 
syndrome occurring mainly in patients after congenital heart surgery. The term 
includes many different arrhythmias, e.g., sinus arrest, sinus node exit block, sinus 
bradycardia, or even a mixture of all of them. Moreover, episodes of tachycardia 
might occur in the form of so-called tachycardia-bradycardia syndrome.  
Severe bradycardia can be hemodynamically relevant and cause hypoperfusion of 
the organs resulting in dizziness and syncope. If there is no underlining disease that 
can be cured, the treatment is either medication or the implantation of a cardiac 
pacemaker. 
	  
 
1.4 Goal of the study 
	  
Arrhythmia is still one of the main complications after FO. The aim of this study has 
been to evaluate the incidence, forms, and clinical consequences of arrhythmia and 
its relationship to the surgical technique in the early postoperative period after 
Fontan repair.   
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2 Patients and methods 
 
2.1 Collective of patients 
	  
From March 2004 until June 2012, 171 patients underwent the Fontan procedure at 
a single institution (Pediatric Cardiac Surgery, Klinikum Großhadern, Ludwig 
Maximilian University, Munich).  
All medical records, including clinical parameters, medication, echocardiography 
results, electrocardiograms, cardiac catheterization results, and operative reports, 
were retrospectively reviewed.  
2.1.1 Demographic data 
	  
Fifty-six (32.7%) children underwent the LT Fontan procedure and 113 (66.1%) the 
EC FO. Two children (1.2%) were treated with the semi intra- semi EC Fontan type 
procedure and were therefore excluded from the study. The remaining 169 children 
constitute the study population. 
Preoperative available data were analyzed retrospectively from birth until the day of 
FO.  
Of the children, 100 (59.2%) were male and 69 (40.8%) female. At the time of FO, 
the mean age was 3.7 ± 2.9 years, mean weight 14.6 ± 7.3 kg, and mean height 
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97.1 ± 16.9 cm (median: age (y) 2.8 (1.3-21.1), weight (kg) 12.6 (7.7-64.7), height 
(cm) 92 (74-176)).  
	  
	  
2.1.2 Malformations 
 
The type of cardiac malformation was assessed by echocardiography and cardiac 
catheterization. The most common malformations were: hypoplastic left heart 
syndrome (HLHS) - 86 (50.9%), HLHS Variants – 23 (13.6%), hypoplastic right heart 
syndrome (HRHS) - 22 (13.0%), HRHS Variants - 13 (7.7%), and double inlet left 
ventricle (DILV) - 14 (8.3%) (Figure 3). The HLHS Variants group included 
malformations such as unbalanced atrioventricular canal with hypoplastic left 
ventricle or double outlet right ventricle with hypoplastic left ventricle. The HRHS 
Variants group included malformations such as unbalanced atrioventricular canal 
with hypoplastic right ventricle or tricuspid atresia with transposition of the great 
arteries. In some patients, additional malformations were present, e.g., dextrocardia 
in 3 cases (1.8%), heterotaxy syndrome in 15 (8.9%).  
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Figure 3: Congenital heart defects in all patients. 
 
 
With regard to the anatomy of the single ventricle, single left ventricle (SL), single 
right ventricle (SR), and common ventricle (CV) were distinguished in the patients 
(SL 48 (28.4%), SR 112 (66.3%), CV 9 (5.3%)). 
	  
2.1.3 Hemodynamic type of heart malformations  
	  
The hemodynamic type of the single ventricle was analyzed, and four types were 
distinguished: before surgical treatment, 32 (18.9%) of the children had reduced 
lung perfusion, 101 (59.8%) had reduced systemic perfusion, 22 (13.0%) had no 
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reduced perfusion in both circulations with pulmonary overcirculation, and 14 (8.3%) 
had balanced systemic and pulmonary circulations.  
	  
2.1.4 Clinical status before Fontan operation  
	   	  
More than one third of the patients had a reduced exercise capacity (67 (39.6%)) 
and about half of the patients presented signs of cyanosis (88 (52.1%)) with a mean 
oxygen saturation of 80.1 ± 6.1%. Fifty (29.6%) children presented cyanotic 
deformed fingers (clubbed fingers). Dyspnea at rest was nearly absent (5 (3.0%)).  
Most of the patients had undergone anticoagulant therapy before FO: 111 (65.7%) 
with acetylsalicylic acid (ASA), 7(4.1%) with phenprocoumon (Marcumar), and 2 
(1.2%) with enoxaparin (Clexane). Some of them received medication affecting the 
heart rhythm, for example, with arrhythmogenic side effects (31 (18.3%)), e.g., 
digoxin, L-thyroxin, antiepileptics. 
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2.2 Data analysis 
	  
	  
All medical records were retrospectively reviewed. Data analyses included clinical 
parameters, medication, echocardiography reports, electrocardiograms, cardiac 
catheterization results, and surgical intervention reports.  
With respect to the FO, the time of cardiopulmonary bypass (CPB), aortic cross-
clamping, intubation (mechanical ventilation), intensive care unit, and hospital stay 
were evaluated. 
After FO, mortality, the necessity of re-operation, medication, the clinical status of 
the patients including complications, electrocardiograms, and echocardiography 
reports were analyzed.  
Development of arrhythmia was detected. Arrhythmia was defined as all forms of 
rhythm other than normofrequent sinus rhythm (NFSR). Hence, the term arrhythmia 
in the following analyses includes bradycardiac or tachycardiac sinus rhythm, 
junctional ectopic rhythm (normofrequent, bradycardic, tachycardic), and atrial 
ectopic rhythm (normofrequent, bradycardic, tachycardic). Parameters that might 
influence the incidence of arrhythmia were of special interest (e.g., age at Fontan 
repair, incidence of arrhythmia before Fontan repair, medication, types of cardiac 
malformations, and the type of Fontan procedure). The analysis also encompassed 
several parameters that might be influenced by the occurrence of arrhythmia, e.g., 
duration of hospitalization, intubation time, need of anti-arrhythmic medication, 
incidence of thromboembolism, and other complications.  
With regard to the complications, the following definitions were used:  
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- prolonged effusion: need for a draining system for longer than 10 days or/and total    
amount of effusion in at least one system (left pleural, right pleural, or pericardial 
drainage) of more than 1000 ml. 
- infection: secondary increase of infection parameters. 
- renal failure: acute renal failure with need of dialysis. 
- thromboembolism: thromboembolic event that caused organ ischemia diagnosed 
clinically or by imaging diagnostics. 
- convulsion: clinical convulsion / seizure symptoms. 
- stroke: clinical stroke or stroke-like symptoms confirmed by imaging diagnostics. 
- bleeding: bleeding that required re-operation/surgical revision.  
 
 
2.3 Palliative operations before Fontan 
operation  
	  
2.3.1  First stage operation 
	  
In the neonatal period, 98 (58.0%) of the patients underwent the Norwood 
procedure (atrial septectomy, pulmonary artery to ascending aorta association with 
pulmonary artery homograft reconstruction of the aortic arch). Of these patients, 19 
children (19.4%) had a combination of the Norwood procedure with a 3.5- or 4-mm 
Blalock-Taussig (BT) shunt (expanded polytetrafluoroethylene (ePTFE) tube, 
IMPRA® ePTFE Vascular Graft, BARD, Tempe, USA; Gore-Tex Vascular Graft, 
W.L. Gore&Associates, Dundee, Scotland, UK). In 79 newborns (80.6%), the 
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Norwood procedure was combined with a right ventricle-to-pulmonary artery (RV-
PA) shunt with a 5-mm ePTFE tube graft.  
Thirty-three (19.5%) patients underwent an aortopulmonary shunt, 23 (13.6%) 
children required pulmonary artery banding, and in 9 (5.3%) children, an atrial 
septectomy was carried out. Aortic arch reconstruction was needed in 9 (5.3%) of 
the patients, and coarctation of the aorta repair in 4 (2.4%). Fourteen (8.3%) 
patients had no first stage operation, but directly underwent the second stage 
procedure. 
 
2.3.2 Second stage operation 
 
All patients underwent a partial cavo-pulmonary anastomosis before Fontan repair 
(hemi-FO or bidirectional Glenn operation).  
2.3.2.1  Hemi-Fontan operation 
	  
Fifty-four (31.9%) patients underwent a hemi-Fontan procedure. The mean age at 
this operation was 10.428±11.28 months (median age (m): 7.88 (3.24-82.44)). The 
surgical technique included division of the systemic-to-pulmonary artery shunt, 
association of the superior vena cava with the right pulmonary artery followed by the 
augmentation of pulmonary arteries by using a homograft patch, revision of 
interatrial communication (if necessary, it was enlarged), and separation of the 
atrium from the cavopulmonary anastomosis by using a PTFE patch. Of these 
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patients, 53 children underwent the LT FO as a third stage operation; a single 
patient underwent an EC FO. 
2.3.2.2  Bidirectional Glenn operation 
	  
The other 115 patients underwent a Glenn anastomosis. The mean age for this 
operation was 13.44 ± 25.2 months (median age (m): 6.888 (2.56-196.8)). The 
technique involved the dividing of the superior caval vein at its junction with the right 
atrium, over-sewing the atrial end, and creating an end-to-side anastomosis 
between the SVC and the right pulmonary artery. 
Thirteen patients had bilateral bidirectional Glenn operation.  
Of the patients after the Glenn anastomosis, 112 underwent the EC FO later on, but 
only 3 a LT FO.  
2.3.2.3 Interstage interventions  
	  
In children with aortic re-coarctation, dilation (27 (16.0%)) or stent-implantation (2 
(1.2%)) was required. Three (1.8%) of the children needed a pacemaker insertion 
even before Fontan; in one of the cases, the surgical implantation of the pacemaker 
was carried out before Fontan,  in the second child, this treatment was performed 
after the second stage operation, and in the third child, the timing of the implantation 
was unknown.  
Three (1.8%) children underwent the Rashkind procedure. RPA/LPA dilation or stent 
implantation was necessary in 36 (21.3%) cases.  
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2.4 Fontan operation 
	  
2.4.1 Intracardiac Fontan operation – lateral atrial tunnel 
(LT) 
 
Fifty-six patients underwent a LT FO. All operations were performed by the same 
surgical team through a median re-sternotomy. The ascending aorta / neoaorta and 
the inferior and superior caval vein were cannulated, and a hypothermic CPB was 
established. All operations were performed without circulatory arrest. The body 
temperature during the operation was around 30°C. Myocardial protection was 
achieved with crystalloid Bretschneider cardioplegic solution (4°C, 30 ml/kg).  
The patch that separated the atrium from the cavopulmonary anastomosis was 
completely excised. A new patch was cut from a portion of a 10-mm ePTFE tube. In 
53 (94.6%) patients, this patch was fenestrated (fenestration about 3 mm in 
diameter). The patch was then sutured into the right atrium, creating a lateral atrial 
tunnel. The atriotomy was closed by using the sandwich technique (Figure 4). 
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Figure 4: Lateral atrial tunnel after the hemi-Fontan operation. 
	  
2.4.2 Extracardiac Fontan operation – extracardiac 
conduit (EC) 
 
One hundred and thirteen patients underwent an EC FO. The procedure was 
performed on the beating heart without aortic cross-clamping in nearly all of the 
patients (100 (88.5%)). After cannulation of the aorta and both caval veins, a 
normothermic CPB was commenced. The inferior caval vein was divided from the 
right atrium and then anastomosed with an ePTFE (Gore-Tex Vascular Graft, W.L. 
Gore&Associates, Dundee, Scotland, UK) conduit (18 or 20 mm in diameter). 
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Opposite to the Glenn anastomosis, the right pulmonary artery was longitudinally 
opened and associated with the ePTFE conduit side-to-end (Figure 5).     
If needed, the cardioplegic cardiac arrest was used to correct intracardiac lesions 
through the right atrial approach. At the same time, the atrial septum was inspected 
for adequate interatrial communication. The atrial opening was then closed with a 
running polydioxanon 5-0 suture. The PTFE stretch conduit was pulled down so that 
it was connected with the inferior caval vein. The length of the conduit was between 
5 and 7cm. The anastomosis of the conduit with the inferior caval vein and the right 
pulmonary artery was performed with a running monofilament polypropylene 5-0 
suture.  
 
Figure 5: Extracardiac Fontan operation. 
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2.5 Examinations  
	  
All patients underwent the same examinations before FO. For each patient, the 
following procedures were carried out: clinical examination, measurement of oxygen 
saturation, electrocardiogram, echocardiography, and cardiac catheterization.  
2.5.1 Electrocardiogram 
	  
Electrocardiographic examination was performed with a 12-channel ECG and 24h-
ECG (Holter). Each patient underwent a 12-channel ECG analysis directly before 
FO, within 12 hours after FO, and the day before discharge. If any abnormalities 
were noted, the children also underwent 24h-ECG (Holter) during hospitalization 
after the Fontan procedure.  
Heart frequencies were classified by the age-adjusted norms (if below – 
bradycardia, if above – tachycardia). Sinus rhythm was defined as a regular p wave 
followed by a normally shaped narrow QRS complex in a 1:1 ratio. In junctional 
ectopic rhythm, the AV node provides electrical impulses, and the p wave lies just 
before or after the QRS complex. Atrial ectopic rhythm was defined as a rhythm with 
differently shaped p waves coming from different impulse-generating spots in the 
atrium.  
2.5.2 Echocardiography 
	  
Each patient underwent a comprehensive preoperative two-dimensional and 
Doppler echocardiographic examination (ECHO). Atrioventricular valve and aortic 
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valve insufficiency was graded on a scale from 1 to 3 (mild, moderate, severe). 
Echocardiography was also used for the qualitative assessment of the ventricular 
hypertrophy (mild, moderate, severe) and the function of the single ventricle (good, 
reduced, poor). 
2.5.3 Cardiac catheterization 
	  
Cardiac catheterization and angiography with the standard technique was 
performed in 169 (100%) children in the median interval time before FO of 1 day (0–
5 d). The main hemodynamic parameters obtained during the procedure were 
pulmonary venous wedge pressure, pulmonary artery pressure, superior and inferior 
caval pressures, ventricular pressures, aortic pressures, superior vena cava and 
aortic saturation, and partial arterial oxygen tension (pO2). Calculations of the 
pulmonary-to-systemic blood flow (Qp:Qs) ratio were carried out by using the Fick 
principle. Data from routine blood tests performed before catheterization (hematocrit 
value, hemoglobin concentration, red blood cell count) were also collected. 
	  
2.5.4 Effusions 
	  
The amount and duration of pleural and peritoneal effusions were analyzed. Right 
pleura drainage was routinely installed during the FO, and left pleura drainage was 
caarried out postoperatively with local anesthesia if needed (clinically significant 
amount of fluid). The strategy was to leave the drainage in place until the daily 
amount of effusion was less than 3 ml/kg.  
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2.6 Statistical analysis 
	  
	  
Nonparametric variables are described as frequencies and percentage. Continuous 
variables are expressed as means with standard deviation (SD) or medians with 
range. The two-tailed Student’s t-test or Mann-Whitney U-test was performed for 
comparison of continuous variables between the groups. Pearson’s chi-squared test 
was used to evaluate differences in the frequency distribution of nonparametric 
variables in two groups. A binary logistic regression was included to re-evaluate the 
influences on the development of arrhythmia. A p-value (P) of less than 0.05 was 
considered significant. 
Statistical analysis was performed with IBM SPSS Statistical Software Version 21.  
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3  Results 
	  
3.1   Differences between LT and EC patients 
before Fontan operation 
	  
3.1.1 Preoperative demographics and morphologic 
features 
	  
Patient age, weight, and height did not differ significantly between the groups (mean 
age: LT 3.7 ± 2 vs EC 3.6 ± 2.9 y, P 0.699; mean weight: LT 14.8 ± 8 vs EC 14.1 ± 6 
kg, P 0.526; mean height: LT 97.9 ± 15 vs EC 95.7 ± 16 cm, P 0.386) (Table 1). 
With regard to gender, more boys were found in the LC group than girls 
(male:female ratio – LT 76.8:23.2% vs EC 50.4:49.6%, P 0.001). 
The most common malformations were: HLHS, HLHS Variants (such as CAVC + 
hypoplastic left ventricle or DORV + hypoplastic left ventricle), HRHS, HRHS 
Variants (such as CAVC + hypoplastic right ventricle or TA + TGA), and DILV. In 
some patients, additional malformations were present, e.g., dextrocardia and 
heterotaxia (see Table 1 and Figure 6 for detailed numbers). 
With respect to the anatomy of the univentricular heart, single left ventricle, single 
right ventricle, and common ventricle were distinguished (28.4% SL – LT 14.3 vs EC 
35.4%, 66.3% SR – LT 82.1 vs EC 58.4%, 5.3% CV – LT 3.6 vs EC 6.2%). The 
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most frequently seen was the single right ventricle, which was overrepresented 
especially in the LT group.   
Four preoperative hemodynamic types were distinguished: reduced lung perfusion, 
reduced systemic perfusion, balanced perfusion, and no reduced perfusion: 18.3% 
(LT 12.5 vs EC 21.2%, P 0.167) of the children had a reduced lung perfusion, 60.4% 
(LT 73.2 vs EC 54.0%, P 0.016) a reduced systemic perfusion, 13.0% (LT 12.5 vs 
EC 13.3%, P 0.888) had no reduced perfusion, and 8.3% (LT 1.8 vs EC 11.5%, P 
0.031) had balanced circulations.  
	  
 LT EC P 
male 43 (76.8%) 57 (50.4%) 0.001 
Sex 
female 13 (23.2%) 56 (49.6%)  
Age (y)   3.7±2 3.6±2.9 0.699 
Hight (cm)   97.9±15 95.7±15.9 0.386 
Weigth (kg)   14.8±8 14.1±6.1 0.526 
HLHS 
HLHS Variants 
36 (64.3%) 
8 (14.3%) 
50 (44.3%) 
15 (13.3%) 
0.014 
0.857 
HRHS 5 (8.9%) 17 (15.0%) 0.266 
HRHS Variants 2 (3.6%) 11 (9.7%) 0.157 
DILV 2 (3.6%) 12 (10.6%) 0.118 
others 3 (5.3%) 8 (7.1%) 0.669 
Isomerism/ 
Heterotaxy 
syndrome 
5 (8.9%) 9 (8%) 0.831 
Malformation 
Dextrocardia 0 (0%) 3 (2.7%) 0.55 
Single Left 
Ventricle 
8 (14.3%) 40 (35.4%) 0.004 
Single Right 
Ventricle 
46 (82.1%) 66 (58.4%) 0.002 Ventricular 
morphology 
Common 
Ventricle 
2 (3.6%) 7 (6.2%) 0.475 
Table 1: Preoperative demographics and morphologic features.  
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Figure 6: Congenital heart defects in the two study groups. 
	  
3.1.2 Operations and other interstage interventions 
before Fontan procedure 
	  
All of the patients received several or at least one palliative operation before the 
Fontan procedure. The usual sequence after the preliminary stage and depending 
on the hemodynamic type of the single ventricle was:  
bidirectional Glenn operation – EC  
or hemi-FO – LC . 
Nearly all of the children underwent the operations in the above-mentioned 
sequence. Only three patients of the LT group had a bidirectional Glenn operation 
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before the Fontan procedure, and a single patient from the EC group had a hemi-
FO. 
Regarding the first stage operations, some differences occurred between the two 
groups of Fontan repair (see Table 2 and 3). 
 
 
LT 
(N = 56) 
EC 
(N = 113) 
P 
Norwood + RV PA shunt 39 (69.6%) 40 (35.4%) < 0.001 
Norwood + BT shunt 1 (1.8%) 18 (15.9%) 0.006 
PA-banding 5 (8.9%) 18 (15.9%) 0.212 
Aortopulmonary shunt 8 (14.3%) 24 (21.2%) 0.277 
Atrioseptectomy 0 5 (4.4%) 0.117 
Pacemaker implantation 1 (1.8%) 2 (1.8%) 0.994 
Table 2: Surgical interventions before Fontan operation. 
	  
 
 
LT 
(N = 56) 
EC 
(N = 113) 
P 
Aortic balloon dilation 10 (17.9%) 13 (11.5%) 0.257 
Aortic stent implantation 0 3 (2.7%) 0.219 
LPA/RPA stent implantation 6 (10.7%) 6 (5.3%) 0.198 
Rashkind procedure  2 (3.6%) 2 (1.8%) 0.468 
MAPCA closure  6 (10.7%) 6 (5.3%) 0.198 
Table 3: Cardiologic interventions carried out some time (month-years) before Fontan 
operation.  
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Some of the children needed a pacemaker implantation even before Fontan repair 
(LT 1.8% (1) vs EC 1.8% (2), P 0.994): this occurred after the second stage 
operation in one case from the EC group and in one case from the LT group. One 
child from the EC group required pacemaker implantation even before the Glenn 
operation.   
The reasons for the need of a permanent pacemaker were sick-sinus-syndrome (1 - 
EC) and AV block III° (2 – 1 EC and 1 LT). 
3.1.3 Clinical status before Fontan procedure 
	  
Apart from the reduced exercise capacity (LT 61.9% vs EC 42.9%, P 0.041), no 
differences were noted between the groups with regard to the clinical status of the 
children (Table 4). Half of the patients in both groups presented signs of cyanosis 
(LT 52.9 vs EC 55.1%, P 0.795) with a mean oxygen saturation of 80.1 ± 6.1 (LT 
79.4 ± 6.01 vs EC 80.8% ± 5.8 mmHg, P 0.346). 28.4% of the children presented 
cyanotic deformed fingers (clubbed fingers) (LT 35.7 vs EC 24.8%, P 0.138). 
Dyspnea at rest was nearly absent (LT 2.1 vs EC 3.8%, P 0.543).  
 LT EC P 
Sat O2 (mean, mmHg) 79.4±6.01 80.8±5.8 0.346 
 Cyanosis 27 (52.9%) 59 (55.1%) 0.795 
 Fingers, cyanotic signs 20 (35.7%) 28 (24.8%) 0.138 
 Reduced exercise capacity 26 (61.9%) 39 (42.9%) 0.041 
 Dyspnea at rest 1 (2.0%) 4 (3.8%) 0.543 
Table 4: Clinical status before Fontan procedure. 
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3.1.4 Medication before Fontan procedure 
	  
Most of the patients received an anticoagulant therapy. Some of them were on 
medication with arrhythmogenic side effects, e.g., digoxin, L-thyroxin, and 
antiepileptics (LT 19.6%, EC 17.7%; see Table 5 for all details). 
 
 All LT EC P 
Diuretics  54 (32%) 19 (33.9%) 35 (31.0%) 0.698 
ACE blockers  83 (49%) 41 (73.2%) 42 (37.2%) <0.001 
ß blockers  2 (1.2%) 1 (1.8%) 1 (0.9%) 1.000 
Digoxin  17 (10%) 7 (12.5%) 10 (8.8%) 0.458 
Rhythm side effect 
medication (all)  
31 (18.3%) 11 (19.6%) 20 (17.7%) 0.759 
Others  9 (5.3%) 3 (5.4%) 6 (5.3%) 0.990 
ASA  51 (100%) 57 (87.9%) 0.009 
enoxaparin  0 (0.0%) 2 (3.0%) 0.503 
Anticoagulation 
 
phenprocoumon  0 (0.0%) 6 (9.1%) 0.026 
 
Table 5. Medication before Fontan operation. 
	  
 
3.1.5 Arrhythmias before Fontan procedure 
	  
With regard to the ECG findings, the two groups also did not differ from each other 
(Table 6, Figures 7 and 8). Most of the patients manifested preoperatively sinus 
rhythm (including normofrequent SR, sinus bradycardia, and sinus tachycardia) (LT 
89.3 vs EC 86%). A NFSR was most frequent (LT 64.3 vs EC 68.2%, P 0.612). Only 
a few children had an atrial ectopic rhythm (LT 5.4 vs EC 11.2%, including atrial 
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ectopic normofrequent rhythm, LT 5.4 vs EC 8.9%, P 0.548; AET, LT 0 vs EC 2.8%, 
P 0.552), or junctional ectopic rhythm (all of these junctional ectopic bradycardia, LT 
3.6 vs EC 0.9%, P 0.272). Some showed branch blocks or AV blocks. Two children 
had a regular pacemaker rhythm (LT 1(1.8%) vs EC 1 (0.9%), P 0.994) (one child 
with a pacemaker underwent no ECG before operation).  
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LT 
(N = 56) 
EC 
(N = 107) 
P 
Sinus rhythm nfq 36 (64.3%) 73 (68.2%) 0.612 
Atrial ectopic nfq 3 (5.4%) 9 (8.4%) 0.548 
Junctional ectopic nfq 0 0  
Sinus tachycardia 11 (19.6%) 16 (15.0%) 0.444 
Atrial ectopic tachycardia 0 3 (2.8%) 0.552 
Junctional ectopic tachycardia 0 0 - 
Sinus bradycardia 3 (5.4%) 3 (2.8%) 0.411 
Atrial ectopic bradycardia 0 0 - 
Junctional ectopic bradycardia 2 (3.6%) 1 (0.9%) 0.272 
Bradycardia all 5 (8.9%) 4 (3.7%) 0.277 
Tachycardia (without sinus) 0 3 (2.8%) 0.552 
AV blocks (degree I°) 4 (7.1%) 3 (2.8%) 0.168 
Right bundle branch block 12 (21.4%) 12 (11.1%) 0.076 
Right bundle branch block 
incomplete 
16 (28.6%) 17 (15.7%) 0.052 
Left bundle branch block 3 (5.4%) 2 (1.9%) 0.216 
Left bundle branch block incomplete 0  5 (4.6%) 0.102 
VES (ventricular extrasystoles) 0 7 (6.2%) 0.057 
Table 6. Rhythm forms and conduction abnormalities before Fontan. 
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Figure 7. Rhythm forms before Fontan procedure. 
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Figure 8. Rhythm forms before Fontan procedure. 
	  
3.1.6 Echocardiography before Fontan procedure 
	  
The preoperative echocardiography showed sufficient to excellent ventricular 
function of the single ventricle in nearly all patients of both groups (LT 50 (89.4%) vs 
EC 102 (90.3%), P 0.842). Almost none of the patinets had reduced ventricular 
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function (LT 2 (3.6%) vs EC 0 (0%), P 0.108). Hypertrophy or dilation of the ventricle 
but with good function affected just a few children (LT 3 (5.4%) vs EC 2 (1.8%), P 
0.195). Severe AV valve insufficiency was present in only a few cases (LT 5 (8.9%) 
vs EC 8 (7.5%), P 0.431) (Table 7). 
	  
	  
 LT EC P 
none 16 (28.6%) 39 (36.4%) 0.463 
I° 19 (33.9%) 34 (31.8%) 0.613 
II° 16 (28.6%) 26 (24.3%) 0.671 
AV valve 
insufficiency 
III° 5 (8.9%) 8 (7.5%) 0.431 
I° 16(28.6%) 32 (28.3%) 0.973 Aortic valve 
insufficiency II° 1 (1.8%) 4 (3.5%) 0.526 
 
Table 7.  Valve insufficiency before Fontan operation. 
	  
 
3.1.7 Cardiac catheterization before Fontan procedure  
	  
The two groups did not differ with respect to the mean pulmonary artery pressure, 
ventricular end-diastolic pressure or pulmonary resistance. They only differed with 
regard to the aortic oxygen saturation and Qp:Qs ratio (mean aortic saturation: LT 
83.7% vs EC 86%, P 0.019; median Qp:Qs: LT 0.62 vs EC 0.74, P 0.006). All 
catheterization results before FO are presented in Table 8.  MAPCAs, which needed 
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to be coiled, were present in both groups (LT 30 (53.6%) vs EC 51 (45.1%), P 
0.301; Table 9). 
The aortic oxygen saturation was the same in patients with MAPCAs (Ao Sat 
80.5±5.6%) and those without (Ao Sat 79.7±6.5%) (P 0.418). No statistically 
significant difference was seen in the aortic oxygen saturation in children with a 
relevant pulmonary artery stenosis (Ao Sat with RPA or LPA stenosis 83.2±5.7% vs 
without RPA or LPA stenosis 85.6±5.4%, P 0.061). 
 LT EC P 
PVRIx (RU/m2) 1.51±0.90 1.56±0.70 0.764 
SVRIx (RU/m2) 13.24 ±4.85 13.86±5.45 0.551 
 Qp:Qs 0.62* (0.34-1.36) 0.74* (0.2-2.01) 0.006 
Sat Ao (%) 83.69±5.5 85.95±5.39 0.019 
Sat SVC (%) 66.24±7.2 65.13±7.67 0.427 
PA MP (mmHg) 11.39±3.13 11.12±2.49 0.577 
RA MP (mmHg) 6.65±2.45 6.59±2.35 0.891 
LA MP (mmHg) 7.18±2.39 6.91±2.19 0.503 
SV EDP (mmHg) 10.38±3.26 10.53±3.51 0.804 
Ao Asc SP (mmHg) 89.19±14.86 87.02±13.27 0.385 
Ao Asc DP(mmHg) 45.46±9.07 45.49±8.29 0.931 
Table 8: Cardiac catheterization data before Fontan operation presented as means with 
standard deviation or (*) medians with range (Ao – aorta, AoAsc – aorta ascendens, Ix – indexed 
for body surface area, DP - diastolic pressure, LA – left atrium, MP – mean pressure, PA – 
pulmonary artery, PVR – pulmonary vascular resistance, Qp:Qs – pulmonary-to-sytemic-flow 
ratio, RA – right atrium, RU – resistance unit = Wood unit, Sat – oxygen saturation, SP – systolic 
pressure, SVC – superior vena cava, SVR – systemic vascular resistance). 
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LT 
(N = 56) 
EC 
(N = 113) 
P 
MAPCA coil 30 (53.6%) 51 (45.1%) 0.301 
Aortic stent implantation 0  3 (3.1%) 0.216 
Aortic dilation 1 (1.8%) 1 (0.9%) 0.610 
RPA/LPA dilation/stent 
implantation 
12 (21.4%) 12 (10.6%) 0.058 
 
Table 9: Interventions during cardiac catheterization shortly (1-5 days) before Fontan operation. 
	  
	  
	  
3.2 Operation 
	  
Patients from both groups needed a cardiopulmonary bypass (CPB) with a median 
time of 56.5(23-214) min (LT 61(36-122) vs EC 49.5(23-214) min, P 0.004). Only 
11.5% operations in the EC group were carried out with aortic cross-clamping, 
whereas in the LT group, all patients needed aortic cross-clamping. The mean time 
for aortic cross-clamping, if needed, was 35.7 ± 13.4 min (LT 34.9 vs EC 39.4min, P 
0.484) (Table 10). In 55 (36.9%) of the children, Fontan repair was performed with 
fenestration (LT 53 (96.4%) vs EC 2 (2.1%), P < 0.001).  
In some of the children, additional operations were performed during FO (Table 11).  
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 LT EC P 
CPB time (min) 61* (36-122) 50* (23-214) 0.004 
Aortic cross-clamping time (min) 34.85±10.4 39.38±22.1 0.484 
Table 10: Cardiopulmonary bypass (CPB) and aortic cross-clamping time during operation 
presented as means with standard deviation or (*) medians with range.  
 Table 11: Additional procedures during Fontan operation.  
	  
	  
	  
	  
	  
 All LT EC P 
AV valve reconstruction 11 (6.5%) 6 (10.7%) 5 (4.4%) 0.119 
Closure of pulmonary valve 5 (3.0%) 0 (0%) 5 (4.4%) 0.110 
Atrioseptectomy 7 (4.1%) 4 (7.1%) 3 (2.7%) 0.168 
Aortic arch enlargement 2 (1.2%) 0 (0%) 2 (1.8%) 0.317 
VSD enlargement 2 (1.2%) 1 (1.8%) 1 (0.9%) 0.610 
Pacemaker implantation 3 (1.8%) 2 (3.6%) 1 (0.9%) 0.213 
Change of pacemaker 1 (0.6%) 0 (0%) 1 (0.9%) 0.480 
Pacemaker electrode 
placement  
2 (1.2%) 0 (0%) 2 (1.8%) 0.317 
Closure RV-PA/BT-Shunt  1 (0.6%) 0 (0%) 1 (0.9%) 0.480 
Enlargement of Glenn 4 (2.4%) 0 (0%) 4 (3.5%) 0.154 
RPA/LPA dilation 5 (3.0%) 2 (3.6%) 3 (2.7%) 0.741 
Fenestration 55(32.5%) 53(96.4%) 2 (2.1%) < 0.001 
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3.3 Postoperative course 
	  
The children stayed within the intensive care unit (ICU) for the mean time of 5.3 
days (LT 5.5 ± 3 vs EC 5.3 ± 5 d, P 0.760), and the median duration of 
hospitalization was 15 (6-67) days (LT 13(6-38) vs EC 16(6-67) d, P 0.016). The 
mean intubation time was 17.73 hours (LT 12.51 ± 20.76 vs EC 20.8 ± 54 h, P 
0.163) (Table 12). 
 
 LT EC P 
ICU time (days)  5.5±3 5.3±5 0.760 
Hospitalization (days) 13* (6-38) 16* (6-67) 0.016 
Intubation time (hours) 12.5±20 20.8±54 0.163 
Table 12: Postoperative course presented as means with standard deviation or (*) medians with 
range (ICU intensive care unit). 
3.4  Postoperative complications  
	  
	  
Eighty-two (48.5%) patients showed postoperative complications (LT 24 (42.8%) vs 
EC 58 (51.3%); P 0.412), including minor (e.g., secondary infection) and severe 
(e.g., stroke or severe bleeding) complications. Table 13 and Figure 9 show the 
most frequent complications after the Fontan procedure. Few differences were 
noted between the two groups (LT, EC) with regard to the chance of developing 
postoperative complications.  
Arrhythmia, which was one of the complications, will be discussed later.  
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The chance of developing prolonged effusions was higher in EC patients, whereas 
the LT group was more likely to develop postoperative strokes or bleeding 
complications. 
 
Figure 9: Complications after Fontan repair during hospitalization.  
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3.5 Arrhythmia 
3.5.1 Time of onset 
	  
Directly (within 12 h) after FO, 40 (25.2 %) of the children presented NFSR. In 24h 
(Holter) ECG analyzes during hospitalization, 45% had a NSFR, and at the time of 
discharge from hospital, 50% of the patients showed this rhythm.  
Most of the arrhythmia occurred in the first days directly after FO. At the time of 
discharge, most of the patients had a regular sinus rhythm. Table 14 shows the 
development of NFSR in the postoperative course. 
 
3.5.2 Forms of arrhythmia 
	  
Different forms of arrhythmia were detected at various time points (Table 14). 
 All LT EC P 
Prolonged effusions 37(21.9%) 7 (12.5%) 30 (26.5%) 0.038 
Secondary infection 33(19.5%) 10 (17.9%) 23 (20.4%) 0.700 
Renal failure 3 (1.8%) 0 (0%) 3 (2.7%) 0.219 
Convulsion 6 (3.6%) 4 (7.1%) 2 (1.8%) 0.094 
Stroke  1 (0.6%) 1 (1.8%) 0 (0%) 0.154 
Bleeding  2 (1.2%) 2 (3.6%) 0 (0%) 0.043 
Table 13: Complications after Fontan repair during hospitalization. 
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 Early post OP 
(N = 159) 
24h(Holter)ECG  
(N = 60) 
At discharge 
(N = 153) 
Sinus rhythm nfq 40 (25.2%) 27 (45.0%) 76 (49.7%) 
Atrial ectopic nfq 10 (6.3%) 3 (5.0%) 15 (9.8%) 
Junctional ectopic nfq 19 (11.9%) 7 (11.7%) 10 (6.5%) 
Sinus tachycardia 58 (36.5%) 4 (6.7%) 36 (23.5%) 
Atrial ectopic tachycardia 10 (6.3%) 1 (1.7%) 3 (2.0%) 
Junctional ectopic tachycardia 10 (6.3%) 0 0 
Pacemaker  5 (3.1%) 2 (3.4%) 4 (2.6%) 
Sinus bradycardia 2 (1.3%) 3 (5.0%) 5 (3.3%) 
Atrial ectopic bradycardia 0 4 (6.7%) 3 (2.0%) 
Junctional ectopic bradycardia 5 (3.1%) 9 (15.0%) 1 (0.7%) 
Bradycardia all 7 (4.4%) 16 (26.7%) 9 (5.9%) 
Tachycardia (without sinus) 20 (12.6%) 1 (1.7%) 3 (2.0%) 
Table 14: Rhythm forms postoperatively. 
	  
	  
3.5.3 Reasons for arrhythmia 
	  
3.5.3.1  Age  
	  
Arrhythmia, defined as all rhythm forms other than NFSR, after Fontan repair 
occurred in all age groups. The group of 2- to 4-year-old children seemed to have 
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the lowest risk for arrhythmia at any time, even if the variation was not large (Table 
15). 
 
 Age Arrhythmia No arrhythmia 
< 2 y 6/11 (54.5%) 5/11 (45.5%) 
2-4 y 42/119 (35.3%) 77/119 (64.7%) 
4-10 y 12/26 (46.2%) 14/26 (53.8%) 
early 
postoperative 
> 10 y 3/8 (37.5%) 5/8 (62.5%) 
< 2 y 2/11 (18.2%) 9/11 (81.8%) 
2-4 y 24/113 (21.2%) 89/113 (78.8%) 
4-10 y 9/25 (36.0%) 16/25 (46.0%) 
at discharge 
> 10 y 3/9 (33.3%) 6/9 (66.7%) 
< 2 y 2/11 (18.2%) 9/11 (81.8%) 
2-4 y 14/120 (11.7%) 106/120 (88.3%) 
4-10y 6/26 (23.1%) 20/26 (76.9%) 
before Fontan 
OP 
> 10 y 1/8 (12.5%) 7/8 (87.5%) 
Table 15: Arrhyhtmia with respect to age at Fontan operation. 
	  
	  
3.5.3.2 Type of heart malformation and clinical status  
	  
Patients with single left ventricle anatomy were more likely to have NFSR early after 
operation than single right ventricle anatomy patients (SL 15 (33.3%) vs SR 24 
(22%), P 0.142).  
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Patients who developed sinus bradycardia early postoperatively all had single left 
anatomy (SL 2 (4.4%) vs SR 0 (0%), P 0.084). 
All forms of bradycardia taken together at discharge were more frequent in single 
left anatomy than in single right (SL 6 (14.6%) vs SR 2 (1.9%), P 0.006). 
No correlation was noted between reduced systemic perfusion before FO and the 
development of sinus tachycardia and other forms of tachycardia early after FO 
(sinus tachycardia early postoperatively: reduced systemic perfusion 37/99 (37.4%) 
vs no reduced systemic perfusion 21/62 (33.9%), P 0.652; tachycardia without sinus 
tachycardia early postoperatively: reduced systemic perfusion 14/99 (14.1%) vs no 
reduced systemic perfusion 7/62 (11.2%), P 0.601). Patients with reduced lung 
perfusion were more likely to develop sinus tachycardia (sinus tachycardia early 
postoperatively: reduced lung perfusion 13/32 (40.6%) vs no reduced lung perfusion 
45/84 (34.9%), P 0.545; tachycardia without sinus tachycardia early postoperatively: 
reduced lung perfusion 4/32 (12.5%) vs no reduced lung perfusion 17/112 (13.2%), 
P 0.919).  
No correlation was observed between the development of early postoperative sinus 
tachycardia and the ventricle anatomy (SL 15 (33.3%) vs SR 39 (35.9%), P 0.772). 
	  
Significant correlation between hypertrophy and variation of heart rhythm could not 
be seen, either with regard to ECG signs of hypertrophy or in echocardiography 
(Tables 16 and 17). 
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 Sinus NFQ others P 
Hypertrophy 
 
24/86 (27.9%) 
 
62/86 (72.1%) 
 
0.336 
 
Early 
postoperatively 
 
No 
hypertrophy 
16/75 (21.3%) 59/75 (78.7%)  
Hypertrophy 
 
16/32 (50.0%) 
 
16/32 (50.0%) 0.405 
 24h-ECG 
(Holter) No 
hypertrophy 
11/28 (39.3%) 17/28 (60.7%)  
Hypertrophy 
 
38/83 (45.8%) 
 
45/83 (54.2%) 0.298 
 
At discharge 
No 
hypertrophy 
39/72 (54.2%) 33/72 (45.8%)  
Hypertrophy 
 
60/88 (68.2%) 
 
28/88 (31.8%) 
 
0.659 
Pre Fontan 
operation No 
hypertrophy 
50/77 (64.9%) 27/77 (35.1%)  
Table 16: Normofrequent sinus rhythm in children with ECG signs of cardiac hypertrophy 
before Fontan repair.  
	  
 Sinus NFQ others P 
Hypertrophy 0/7 (0.0%) 7/7 (100%) 0.120 
Early 
postoperatively No 
hypertrophy 
40/154 (26.0%) 114/154 (74.0%)  
Hypertrophy 1/3 (33.3%) 2/3 (66.7%) 0.677 
24h-ECG 
(Holter) No 
hypertrophy 
26/57 (45.6%) 31/57 (54.4%)  
Hypertrophy 1/7 (14.3%) 6/7 (85.7%) 0.055 
 At discharge No 
hypertrophy 
76/148 (51.4%) 72/148 (48.6%)  
Hypertrophy 
5/7 (71.4%) 
 
2/7 (28.6%) 0.785 
 Pre Fontan  
operation No 
hypertrophy 
105/158 (66.5%) 53/158 (33.5%)  
Table 17: Normofrequent sinus rhythm in children with echocardiographic signs of cardiac 
hypertrophy before Fontan repair.  
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No significant correlation was detected between the occurrence of heterotaxy 
diagnosis and the incidence of arrhythmia. Only the prevalence for NFSR before 
Fontan repair was significantly lower in patients with heterotaxy syndrome (Table 
18). Dextrocardia was not a risk factor for the development of arrhythmia (P>0.050).  
The type of cardiac malformation had no impact on the development of arrhythmia 
in general.  
 
 Sinus NFQ others P 
Heterotaxy 2/14 (14.3%) 12/14 (85.7%) 0.339 Early 
postoperatively No heterotaxy 38/147 (25.9%) 109/147 (74.1%)  
Heterotaxy 2/5 (40.0%) 3/5 (60.0%) 0.814 24h-ECG 
(Holter) No heterotaxy 25/55 (45.5%) 30/55 (54.5%)  
Heterotaxy 8/14 (57.1%) 6/14 (42.9%)  0.558 
 At discharge 
No heterotaxy 69/141 (48.9%) 72/141 (51.1%)  
Heterotaxy 5/15 (33.3%) 10/15 (66.7%) 0.004  Pre Fontan 
operation No heterotaxy 105/150 (70.0%) 45/150 (30.0%)  
 
Table 18: Normofrequent sinus rhythm in children with heterotaxy syndrome.  
 
Reduced exercise capacity before FO had no significant influence on the 
development of arrhythmia at any time (Table 19). 
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 Sinus NFQ others P 
reduced 15/65 (23.1%) 50/65 (76.9%) 
Early postoperatively 
normal 21/66 (31.8%) 45/66 (68.2%) 
0.262 
reduced 9/26 (34.6%) 17/26 (65.4%) 
24h-ECG (Holter) 
normal 14/25 (56.0%) 11/25 (44.0%) 
0.125 
reduced 27/64 (42.2%) 37/64 (57.8%) 
 At discharge 
normal 36/62 (58.1%) 26/62 (41.9%) 
0.075 
reduced 43/67 (64.2%) 24/67 (35.6%) 
 Pre Fontan operation 
normal 46/67 (68.7%) 21/67 (31.3%) 
0.583 
Table 19: Normofrequent sinus rhytm in children with reduced exercise capacity before Fontan 
operation.  
3.5.3.3 Medication  
	  
Of all arrhythmogenic medication, e.g., catecholamine, cardiac glycosides, or ß 
blocker, only catecholamine therapy showed a significant influence on the 
development of arrhythmia early after FO (Table 20). Other medication had no 
significant impact (Table 21, Table 22).  
 NFQ SR others P 
Early postoperatively 11/66 (16.7%) 55/66 (83.3%) 0.045 
24h(Holter) ECG 11/24 (45.8%) 13/24 (54.2%) 0.916 
At discharge 34/63 (54.0%) 29/63 (46.0%) 0.377 
Table 20: Arrhythmia in patients with catecholamine therapy. 
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 NFQ SR others P 
Early postoperatively 1/7 (14.3%) 6/7 (85.7%) 0.509 
24h(Holter) ECG 2/3 (66.7%) 1/3 (33.3%) 0.439 
At discharge 4/7 (51.1%) 3/7 (42.9%) 0.686 
Table 21: Arrhythmia in patients with cardiac glycoside therapy. 
	  
 NFQ SR others P 
Early postoperatively 0/3 (0%) 3/3 (100%) 0.315 
24h(Holter) ECG 0 0 0 
At discharge 1/3 (33.3%) 2/3 (66.7%) 0.567 
Table 22: Arrhythmia in patients with ß blocker therapy. 
	  
Most children who presented with sinus tachycardia (N 58) or non-sinus tachycardia 
(N 21) were given postoperative adrenalin therapy (postoperatively ST: adrenalin 
therapy 30/58 (51.7%) vs no adrenalin therapy 28/58 (48.3%), P 0.038; non-ST: 
adrenalin therapy 13/21 (61.9%) vs no adrenalin therapy 8/21 (38.1%), P 0.037).  
Children who received postoperative glycoside therapy experienced sinus 
tachycardia more frequently, but not non-sinus tachycardia (cardiac glycosides: ST 
5/7 (71.4%) vs others 2/7 (28.6%), P 0.046; non-ST 1/7 (14.3%) vs others 6/7 
(85.7%), P 0.921). No correlation was seen between other types of medication, e.g., 
milrinon, noradrenalin, dobutamin, or ß blockers, and the development of 
postoperative tachycardia (see tables below for all results). 
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 Therapy -/+ ST -/+ P 
- 67/95 (70.5%) - 95/161 
+ 28/95 (29.5%) 
- 36/66 (54.5%) 
Adrenalin 
+ 66/161 
+ 30/66 (45.5%) 
 
0.038 
 
 
- 101/154 (65.6%) - 154/161 
+ 53/154 (34.4%) 
- 2/7 (28.6%) 
Digoxin 
+ 7/161 
+ 5/7 (71.4%) 
 
0.046 
- 26/35 (74.3%) - 35/161 
+ 9/35 (25.7%) 
- 77/126 (61.1%) 
Milrinon 
+ 126/161 
+ 49/126 (38.9%) 
 
0.151 
- 94/142 (66.2%) - 142/161 
+ 48/142 (33.8%) 
- 9/19 (47.4%) 
Dobuatmin 
+ 19/161 
+ 10/19 (52.6%) 
 
0.108 
- 103/160 (64.4%) - 160/161 
+ 57/160 (35.6%) 
- 0/1 (0%) 
Noradrenalin 
+ 1/161 
+ 1/1 (100%) 
 
0.181 
- 101/158 (63.9%) - 158/161 
+ 57/158 (36.1%) 
- 2/3 (66.7%) 
ß-blockers 
+ 3/161 
+ 1/3 (33.3%) 
 
0.922 
Table 23: Sinus tachycardia in correlation to postoperative medication after Fontan operation. 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
65 
 Therapy -/+ non-ST -/+ P 
- 87/95 (91.6%) - 95/161 
+ 8/95 (8.4%) 
- 53/66 (80.3%) 
Adrenalin 
+ 66/161 
+ 13/66 (19.7%) 
 
0.037 
 
 
- 134/154 (87.0%) - 154/161 
+ 20/154 (13.0%) 
- 6/7 (85.7%) 
Digoxin 
+ 7/161 
+ 1/7 (14.3%) 
 
0.921 
- 32/35 (91.4%) - 35/161 
+ 3/35 (8.6%) 
- 108/126 (85.7%) 
Milrinon 
+ 126/161 
+ 8/126 (14.3%) 
 
0.375 
- 124/142 (87.3%) - 142/161 
+ 18/142 (12.7%) 
- 16/19 (84.2%) 
Dobuatmin 
+ 19/161 
+ 3/19 (15.8%) 
 
0.705 
- 139/160 (86.9%) - 160/161 
+ 21/160 (13.1%) 
- 1/1 (100%) 
Noradrenalin 
+ 1/161 
+ 0/1 (0%) 
 
0.698 
- 138/158 (87.3%) - 158/161 
+ 20/158 (12.7%) 
- 2/3 (66.7%) 
ß-blockers 
+ 3/161 
+ 1/3 (33.3%) 
 
0.292 
Table 24: Non-sinus tachycardia in correlation to postoperative medication after Fontan 
operation. 
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3.5.3.4 CPB time and aortic cross-clamping time 
	  
Patients without NFSR (no NFSR) in the early postoperative period underwent 
significantly longer CPB (median CPB: NFSR 45.5(23-214) min vs no NFSR 59(28-
433) min; P 0.008) during Fontan repair (Table 26). 
Aortal cross-clamping time, if necessary, had no impact on the occurrence of NFSR 
in the early postoperative period (NFSR 38.3 ±15.9 vs no NFSR 35.9±13.6 min; P 
0.625) (Table 26). However, patients who underwent the FO without aortal cross-
clamping showed significantly more NFSR at all times (Table 27). 
Patients who developed junctional ectopic tachycardia (JET) in the first few days 
after Fontan repair had longer periods of CPB, but this was statistically not 
significant (JET mean 95.1±112.9 min vs no JET mean 65.4±35.2 min; P 0.395). 
The cases with postoperative sinus tachycardia (ST) had longer but not significant 
CPB (ST 73.8±38.6 min vs 62.8±47.7 min; P 0.134).  
The occurrence of AET at any time was not influenced by CPB or aortal cross-
clamping time. This also applied to any form of bradycardia. 
 LT EC P 
CPB (min) 61* (36-122) 50* (23-214) 0.004 
Aortic cross-clamping (min) 34.85±10.4 39.38±22.1 0.484 
Table 25: Operation parameters: LT vs EC - presented as means with standard deviation or (*) 
medians with range. 
 Sinus NFQ others P 
CPB (min)* 46* (23-214) 59* (28-433) 0.008 
 Aortic cross-clamping (min) 38.3±15.9 35.9 ±13.6 0.625 
Table 26: Operation parameters: Sinus NFQ vs others early post OP - presented as means with 
standard deviation or (*) medians with range. 
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   Aortic cross-
clamping 
(N = 69) 
None 
(N = 102) 
P 
Sinus rhythm nfq, early post OP 10 (15.6%) 30 (30.9%) 0.028 
Sinus rhythm nfq, 24h(Holter) ECG 12 (37.5%) 15 (53.6%) 0.212 
Sinus rhythm nfq, at discharge 26 (39.4%) 51 (58.3%) 0.027 
Table 27: Normofrequent sinus rhythm in the course of hospitalization in correlation to aortal 
cross-clamping. 
	  
	  
3.5.3.5 First stage operations  
	  
Children who underwent the Norwood operation combined with a RV-PA shunt were 
more likely than those without a combined RV-PA shunt to develop ventricular 
extrasystoles (VES) during hospitalization after FO (VES after Fontan: RV-PA 3/76 
(3.8%), no RV-PA 0/92, P 0.059). However, no correlation was seen between RV-
PA combined with the Norwood operation and the incidence of VES before FO (VES 
before FO: RV-PA 1/79 (1.5%), no RV-PA 6/86 (6.5%), P 0.084).  
	  
	  
	  
3.5.3.6 Effect of Fontan type repair on the development of 
arrhythmia 
	  
The main interest of the study was to analyze the impact of the type of Fontan repair 
on the development of arrhythmia. The two groups were compared regarding all 
possible forms of arrhythmia at the various points of time.  
	  
	  
68 
Directly after Fontan repair, only 23.8% of all patients showed NFSR, whereas 76.2 
% had diverse forms of arrhythmia, including sinus tachycardia and normofrequent 
atrial ectopic rhythm up to JET (for the differences between the two groups LT/EC 
early postoperatively, see Table 28). 
 
 
LT 
N=53 
EC 
N=106 
P 
Sinus rhythm nfq 8 (15.1%) 32 (30.2%) 0.039 
Atrial ectopic nfq 2 (3.8%) 8 (7.5%) 0.498 
Junctional ectopic nfq 11 (20.8%) 8 (7.5%) 0.016 
Sinus tachycardia 13 (24.5%) 45 (42.5%) 0.027 
Atrial ectopic tachycardia 4 (7.5%) 6 (5.7%) 0.732 
Junctional ectopic tachycardia 10 (18.9%) 0 < 0.001 
Pacemaker  3 (5.7%) 2 (1.9%)  
Sinus bradycardia 0 2 (1.9%) 0.553 
Atrial ectopic bradycardia 0 0  
Junctional ectopic bradycardia 2 (3.8%) 3 (2.8%) 1.000 
Bradycardia all 2 (3.8%) 5 (4.7%) 0.785 
Tachycardia(without sinus) 14 (26.4%) 6 (5.7%) < 0.001 
Table 28: Rhythm forms early postoperatively – LT vs EC. 
Directly after Fontan repair, NFSR occurred more frequently in the EC group (LT 
15% vs EC 30.2%, P 0.039). In 24h (Holter) ECG results regarding NFSR, the EC 
group appeared to be superior (LT 30% vs EC 58%, P 0.030). Moreover, at the time 
of discharge, the EC group had a higher incidence of NFSR (LT 36.5% vs EC 56%, 
P 0.020) (Table 31, Figure 10). 
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 Early post OP 
(N = 159) 
24h(Holter) ECG 
(N = 60) 
At discharge 
(N = 153) 
LT(53) EC (106) LT (27) EC (33) LT (52) EC (101)  
Sinus rhythm 
nfq 
8 (15.1%) 32 (30%) 8 (30%) 19 (58%) 19 (37%) 57 (56%) 
Table 29: Normofrequent sinus rhythm in the course of hospitalization.  
 
	  
	  
Figure 10: Normofrequent sinus rhythm in the course of hospitalization.
The incidence of normofrequent atrial ectopic rhythm did not differ significantly 
between the two groups at any time point, even though the EC group seemed to 
show a slightly higher percentage of normofrequent atrial ectopic rhythm (LT 3.8% 
vs EC 7.5%; P 0.498) directly after Fontan repair. 
Normofrequent junctional ectopic rhythm early postoperatively after Fontan repair 
was significantly more frequent in the LT group (LT 20.8% vs EC 7.5%, P 0.016). 
Even more significant results were presented at discharge (LT 17.3% vs 1.0%, P 
<0,001). A similar trend could be seen in long-term ECG analyses (LT 18.5% vs EC 
6%, P 0.135). 
JET during the early postoperative period appeared only in LT patients (LT 18.9% 
vs EC 0%, P < 0.001).  
AET occurred in both groups without significant differences (LT 7.5% vs EC 5.7%, P 
0.644 early post-operative period; LT 1.9% vs EC 2.0%, P 0.981 at discharge). 
Postoperative bradycardia and sinus node dysfunction, excluding the above-
mentioned forms, did not differ significantly between the two groups (LT 3.8% vs EC 
4.7%, P 0.785 early postoperative period; LT 5.8 vs EC 5.9%, P 1.000 at discharge). 
Some patients demonstrated postoperative sinus tachycardia; this was more 
frequent in the EC group (LT 24.5% vs EC 42.5%, P 0.027). However, at the time of 
discharge and in long-term ECG analyses, the two groups did not differ from each 
other with regard to sinus tachycardia (LT 21.2% vs EC 24.8%, P 0.619 at 
discharge; LT 7.4% vs EC 6.1%, P 0.835 in long-term ECG).  
Table 28, 29, 30, and 31 show the rhythm variations between the two groups (LT, 
EC) at the various points of time. Figures 11 to 15 show the different forms of 
ectopic rhythm and their development during hospitalization. 
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LT  
N=27 
EC 
N=33 
P 
Sinus rhythm nfq 8 (29.6%) 19 (57.6%) 0.030 
Atrial ectopic nfq 0 3 (9.1%) 0.245 
Junctional ectopic nfq 5 (18.5%) 2 (6.1%) 0.135 
Sinus tachycardia 2 (7.4%) 2 (6.1%) 0.835 
Atrial ectopic tachycardia 1 (3.7%) 0 0.450 
Junctional ectopic tachycardia 0 0  
Pacemaker  1 (3.7%) 0  
Sinus bradycardia 0 3 (9.1%) 0.245 
Atrial ectopic bradycardia 2 (7.4%) 2 (6.1%) 1.000 
Junctional ectopic bradycardia 7 (25.9%) 2 (6.1%) 0.065 
Bradycardia all 9 (33.3%) 7 (21.2%) 0.291 
Tachycardia(without sinus) 1 (3.7%) 0 0.450 
Table 30: Rhythm forms in 24h-Holter ECG – LT vs EC. 
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LT 
N=52 
EC 
N=101 
P 
Sinus rhythm nfq 19 (36.5%) 57 (56.4%) 0.020 
Atrial ectopic nfq 8 (15.4%) 7 (6.9%) 0.096 
Junctional ectopic nfq 9 (17.3%) 1 (1%) < 0.001 
Sinus tachycardia 11 (21.2%) 25 (24.8%) 0.619 
Atrial ectopic tachycardia 1 (1.9%) 2 (2.0%) 1.000 
Junctional ectopic tachycardia 0 0  
Pacemaker  1 (1.9%) 3 (3.0%)  
Sinus bradycardia 1 (1.9%) 4 (4.0%) 0.662 
Atrial ectopic bradycardia 1 (1.9%) 2 (2.0%) 1.000 
Junctional ectopic bradycardia 1 (1.9%) 0 0.340 
Bradycardia all 3 (5.8%) 6 (5.9%) 1.000 
Tachycardia(without sinus) 1 (1.9%) 2 (2.0%) 1.000 
Table 31: Rhythm forms at discharge – LT vs EC. 
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Figure 11: Normofrequent junctional ectopic rhythm in the course of hospitalization  – LT vs 
EC.  
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Figure 12: Junctional ectopic bradycardia in the course of hospitalization – LT vs EC. 
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Figure 13: Junctional ectopic tachycardia in the course of hospitalization – LT vs EC. 
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Figure 14: Junctional ectopic rhythm in the course of hospitalization - LT vs EC. 
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Figure 15: Atrial ectopic rhythm in the course of hospitalization - LT vs EC. 
	  
3.5.4 Consequences and complications of arrhythmia 
3.5.4.1 Intubation time  
	  
Patients without NFSR (no NFSR) in the early postoperative period had a longer 
intubation time (mean intubation time: NFSR 11.9h vs no NFSR 19.3h, P 0.371) 
after the Fontan procedure, but the differences did not reach statistical significance. 
The cases with postoperative sinus tachycardia (ST) experienced a longer 
intubation time (ST 27.1 h vs no ST 11.8 h, P 0.105). Intubation time was not 
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influenced by the occurrence of AET at any time. This also applied to all forms of 
bradycardia (see Table 32). 
 Intubation time (h) P 
Sinus NFQ 11.9±18.9 0.371 
others 19.3±50.4  
Juncitional ectopic tachycardia 24.5±46.7 0.628 
others 17.0±44.7  
Sinus tachycardia 27.1±68.8 0.105 
others 11.8±19.0  
Table 32: Infuence of rhythm on the intubation time – presented as means with standard 
deviation. 
 
3.5.4.2 Time of hospitalization and ICU time 
	  
No difference was detected between the mean ICU time or time of hospitalization 
between the groups with and without NFSR during the early postoperative period 
(NFSR 4.6 and 17.4 days vs no NFSR 5.4 and 17.3 days, P 0.242 and 0.942, 
respectively).  
The occurrence of JET, AET, or sinus tachycardia had no significant impact on ICU 
time or time of hospitalization. This was similar for all forms of bradycardia. 
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3.5.4.3 Medication during hospitalization 
 
Of those patients who presented with early postoperative non-sinus tachycardia (N 
21), only 9.5% (2/21) required amiodarone, and only 4.5% (1/21) needed 
adenosine. 
Of the patients who presented with postoperative bradycardia, 42.9% (3/7) had 
dopamine as their only medication, with other medication having only a frequency of 
13.6% (20/154), P 0.027.  
3.5.4.4 Medication at discharge 
 
 All LT EC P 
ACE 33 (19.3%) 15 (26.8%) 18 (15.9%) 0.094 
Digoxine 7 (4.1%) 1 (1.8%) 6 (5.3%) 0.279 
ß Blockers 3 (1.8%) 1 (1.8%) 2 (1.8%) 1.000 
Table 33: Medication at discharge – LT vs EC. 
	  
3.5.4.5 Effusions  
	  
Some 22.0% of all children had prolonged effusions. Patients with bradycardia 
during 24h-Holter ECG analyses, especially atrial ectopic bradycardia, tended to 
have more prolonged effusions than others (prolonged effusions: bradycardia 7/16 
(43.8%) vs no bradycardia 7/37 (15.9%), P 0.024; atrial ectopic bradycardia 4/4 
(100%) vs no atrial ectopic bradycardia 10/56 (17.9%), P 0.002). No correlation was 
detected between other forms of arrhythmia at other times of ECG analysis (early 
postoperatively, at discharge) and the development of prolonged effusions. 
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Patients with sinus bradycardia in long-term ECG during hospitalization developed 
higher amounts of pleural effusion on the right side (22.4 (18.4-23.9) ml/kg/d vs 
children without sinus bradycardia 12.3 (2.2-38.8) ml/kg/d, p=0.017).  
	  
 LT EC P 
Pericardial drainage (ml/kg/d) 9.98±15.03 8.48±5.7 0.366 
LP drainage (ml/kg/d) 11.6±10.1 11.4±7.3 0.929 
RP drainage (ml/kg/d) 10.7*(1.2-25) 12.7*(1.3-52) 0.061 
Ascites (ml/kg/d) 61.03±27.77 51.81±52.8 0.749 
Table 34: Effusions during hospitalization – LT vs EC - presented as means with standard 
deviation or (*) medians with range (LP – left pleura, RP – right pleura). 
	  
 LT EC P 
Pericardial drainage (d) 2.55±1.77 2.98±3.09 0.338 
LP drainage (d) 2.20±4.20 2.96±5.42 0.359 
RP drainage (d) 6.16±5.69 8.20±7.62 0.053 
Ascites (d) 0.73±3.02 0.62±2.39 0.793 
Table 35: Duration of effusions – LT vs EC - presented as means with standard deviation. 
 
Even if not statistically significant, the effusions of the RP drainage were of a higher 
amount in patients without fenestration (Table 36). The children with fenestration 
showed lower incidence of prolonged effusions (P 0.030) (Table 37) (12.5 % vs. 
27.7%). 
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 No Fenestration Fenestration P 
Pericardial drainage (ml/kg/d) 8.45±5.9 9.89±15 0.421 
LP drainage (ml/kg/d) 10.66±5.9 11.37±10.4 0.742 
RP drainage (ml/kg/d) 12.98±6.8 10.79±5.3 0.050 
Aszites (ml/kg/d) 38.04±19.3 61.57±26.9 0.098 
Table 36: Effusions during hospitalization (patients with vs without fenestration) - presented as 
means with standard deviation. 
	  
	  
 No Fenestration 
(N = 94) 
Fenestration 
(N = 56) 
P 
None 68 (72.3%) 49 (87.5%) 0.030 
Prolonged effusions 26 (27.7%) 7 (12.5%)  
Table 37: Prolonged effusions - (patients with vs without fenestration). 
	  
Patients with prolonged effusions had a longer duration of hospitalization (P < 
0.001). However, effusions had no impact on ICU time (Table 38). 
 None Prolonged 
effusions 
P 
ICU time (days) 5.0 ± 3.6 6.6 ± 6.3 0.151 
Hospitalization time (days) 13* (5-41) 25* (11-67) < 0.001 
Table 38: Time of ICU or hospitalization in correlation to effusion - presented as means with 
standard deviation or (*) medians with range. 
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3.5.4.6 Temporary heart stimulation 
	  
Temporary pacemaker stimulation (AAI) was required in 24.3% of the patients after 
Fontan repair (LT 44.6% vs EC 14.2%, P < 0.001), but in most cases (88.1%, LT 
92.3 vs EC 81.3%, P 0.281) for less than 5 days.  
The most frequent reason for a temporary pacemaker was a junctional ectopic 
rhythm (75.6%, LT 76.0 vs EC 75.0%), followed by atrial ectopic rhythm (12.2%, LT 
12.0 vs EC 12.5%; Table 39, Figure 16). 
	  
	  
	  
 All  
(N=169) 
LT  
(N=56) 
EC  
(N=113) 
P 
Need for pacing 41 (24.3%) 25 (44.6%) 16 (14.2%) < 0.001 
Junctional ectopic 31/41 (75.6%) 19/25 (76.0%) 12/16 (75.0%) 0.001 
Atrial ectopic 5/41 (12.2%) 3/25 (12.0%) 2/16 (12.5%) 0.334 
Bifascicular block 1/41 (2.4%) 0/25 (0.0%) 1/16 (6.3%) 1.0 
Sinus bradycardia 1/41 (2.4%) 1/25 (4%) 0/16 (0%) 0.331 
Defective pacemaker  1/41 (2.4%) 0/25 (0%) 1/16 (6.3%) 1.0 
Ventricular 
tachycardia 
1/41 (2.4%) 1/25 (4%) 0/16 (0%) 0.331 
Atrioventricular block 1/41 (2.4%) 1/25 (4.0%) 0/16 (0.0%) 0.331 
Table 39: Reasons for postoperative temporary pacemaker stimulation. 
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Figure 16: Reasons for use of postoperative temporary pacemaker.  
	  
	  
	  
3.5.4.7 Permanent heart stimulation  
	  
New implantation of a permanent pacemaker during hospitalization after FO was 
necessary in two (1.2%) of the children (LT 1/56 (0.9%) vs EC 1/113 (1.8%), P 
1.000).  
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3.6 Binary logistic regression 
 
The OP variant (LT, EC), CPB and age at FO were included as covariates in the 
model to value their influence on the development of arrhythmias after FO. 
For this binary logistic regression model the LT OP variant was the only 
independent predictor of the development of arrhythmias after FO. 
LT was the only independent predictor for no NFSR early postoperatively (OR 1.43 
vs EC; P 0.042), in 24h (Holter) ECG (OR 2.22 vs EC; P 0.033) and at discharge 
(OR 1.25 vs EC; P 0.021). 
Besides LT was the only independent predictor for normofrequent junctional ectopic 
rhythm early postoperatively (OR 2.21 vs EC; P 0.02) and at discharge (OR 19.93 
vs EC; P 0.004). In 24h (Holter) ECG no significant influence of the above-
mentioned covariates could be detected by binary logistic regression. 
For the need of postoperatively temporary pacing independent significant predictors 
were LT (OR 3.9 vs EC; P < 0.000) as well as CPB (OR 0.01; P 0.042).  
Additionally including the need for aortal cross-clamping as covariate to the model, 
the binary logistic regression showed slightly different results. Early postoperatively 
the need for aortal cross-clamping is the only independent predictor for no NFSR 
(OR 1.32 vs no aortal cross-clamping; P 0.039). However, LT is still the only 
independent predictor for no NFSR in 24h (Holter) ECG (OR 2.22 vs EC; P 0.033) 
and at discharge (OR 1.25 vs EC; P 0.021).  
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4 Discussion 
	  
The main interest of the study was to determine the effect of Fontan repair on the 
development of arrhythmia in the early period after FO. Arrhythmia is still one of the 
most frequent complications that can lead to morbidity and mortality after FO. 
Therefore, the incidence of arrhythmia needs to be reduced or even avoided.  
The aim of our study has been to detect possible risk factors that might influence the 
occurrence of arrhythmia in Fontan patients. Of special interest has been the 
influence of the type of FO on the development of arrhythmia. Furthermore, 
complications caused by arrhythmia have been analyzed, and other differences 
between the intracardiac (LT) and extracardiac (EC) FO have been detected and 
analyzed. 
All patients included in our study underwent the FO at a single institution. Surgery 
was performed in two constant operative techniques. During the years from 2004 to 
2012, the two modifications of Fontan repair (LT, EC) were performed in parallel. 
Hence, because of both types of FO occurred within the same institution, patients 
from the two groups received the same treatment protocol during operation and 
hospitalization. This is of great value compared with other studies, which often refer 
to a historical group or compare patients form different centers. 
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4.1 Arrhythmia in Fontan patients 
	  
The results of our study clearly show a significantly higher incidence of arrhythmia in 
the first weeks after FO in patients who undergo LT Fontan surgery compared with 
those who had an EC FO. Hence, we wanted to analyze whether the type of Fontan 
repair primarily caused arrhythmia, or whether other variables influenced these 
results. 
	  
4.1.1 Differences before Fontan operation and their 
possible impact on the development of arrhythmia 
after this procedure 
4.1.1.1 Demographic and clinical differences 
	  
Before FO, most of the patients showed NFSR (109, 66.9%). Furthermore, no significant 
difference was noted between the groups regarding the incidence of NFSR before FO (LT 
36(64.3%) vs EC 73(68.2%), P 0.612).  
However the two groups showed other preoperative differences. Thus, our interest was to 
ascertain whether the various forms of FO, rather than demographic differences, triggered 
arrhythmia. The groups showed demographic differences regarding gender and type of 
malformation. In the LT group, boys (P 0.001) and single ventricle of right ventricular 
morphology (P 0.002) were overrepresented. This is because the incidence for HLHS, which 
means a right ventricular morphology, is higher in boys. In general, 70% of all children with 
HLHS are boys. This explains the overrepresentation of boys in the LT group. Nevertheless, 
neither boys nor patients with single right ventricle morphology tended to develop 
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arrhythmia any more frequently after FO than the other patients. We could not find any 
comments in previous studies regarding the influence of sex on the development of 
arrhythmia after FO. However, patients with single right ventricle morphology are known 
generally to have a worse outcome than others [41-43]. This is based on a poorer coronary 
arterial perfusion of the right ventricle [44]. The molecular biology of the right ventricular 
myocardium and the geometry of the ventricle anatomy and the anatomy of the tricuspid 
valve also play an important role [42, 45, 46]. Thus, the single right ventricle has a lower 
cardiac output and a higher atrial pressure [47]. 
In cardiac catheterization performed before FO, the EC group had a higher aortic saturation 
(P 0.019) and a higher pulmonary-to-systemic flow ratio (P 0.006). The possible reason for 
this finding could be that more children in the EC group had an additional pulmonary flow 
source, i.e., apart from Glenn, additional antegrade flow through the main pulmonary artery, 
a still open aortopulmonary shunt, or more collateral vessels (MAPCAs). Before FO, fewer 
of the EC children showed reduced exercise capacity than those from the LT group (P 
0.041). In our study, children who had a reduced exercise capacity before FO were more 
likely not to develop NFSR at discharge after FO (P 0.075). 
Moreover, children with signs of cardiac hypertrophy, which can also be a reason for 
reduced exercise capacity, were more likely not to develop NFSR early postoperatively (P 
0.120) and at discharge (P 0.055). Even if these differences are not significant, other studies 
have described a significantly higher risk for arrhythmia [35] and Fontan failure [48] [41] in 
children with ventricular hypertrophy.  
As well as hypertrophy and single right ventricle morphology, heterotaxy syndrome 
is known to be a risk factor of arrhythmia, as described by Kim et al. [49]. 
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In a study of Stamm et al. [50], heterotaxy was the only patient-related risk factor for 
early and late arrhythmias. In patients with heterotaxy, numerous abnormalities in 
the conduction system are able to activate arrhythmia, irrespective of the type of 
Fontan repair, e.g., twin atrioventricular node, dual sinus node, and atrioventricular 
blocks [51].  
In our study, patients with heterotaxy syndrome presented with higher numbers of 
no NFSR before FO, even though we could not show an elevated risk for arrhythmia 
after Fontan surgery in those patients.  
AV valve insufficiency, as described by Durongpistikul [52], exhibited no relationship 
to arrhythmia after FO in our study.  
In our study, the lowest risk for developing arrhythmia, without considering the type 
of Fontan repair, was for children who underwent FO at the age of 2 to 4 years. This 
differs from the age that was originally set for the FO selection criteria by Choussat 
and his colleagues in 1977. In their selection criteria, they suggested a minimum 
age of 4 years. However, today, these criteria have become less strict [53, 54]. Our 
study shows better outcomes with regard to arrhythmia at discharge for patients of a 
younger age (2-4y). Undergoing FO at a younger age means an overall shorter 
period of time in which the ventricle is exposed to insufficient oxygenated blood. 
Chronic hypoxemia to the ventricle and, therefore, to the conduction tissue is known 
to cause fragility to the system and more fibrosis in the atrial wall. These reactions 
consecutive disturb rhythm conduction and therefore lead to arrhythmia. Another 
reason could be the insufficient AV valve in the single ventricle circulation before 
FO. A longer or higher level of insufficiency of the AV valve means more distension 
of the atria, which in consequence leads to a higher risk for arrhythmia. However, no 
	  
	  
90 
relationship between the level of AV insufficiency before FO and the incidence of 
arrhythmia after FO could be seen in our study. In addition, in general terms, a 
younger organism has a better regeneration potential.  
   
4.1.1.2 Previous operations 
	  
With regard to the influence of operations carried out previously to FO, no difference 
was noted to the prevalence of arrhythmia if the children had undergone a hemi-
Fontan or Glenn operation before FO in our study. Thus, the second stage operation 
(Glenn, hemi-Fontan) seems to have no impact on the development of arrhythmia. 
In a study performed by Reichlin et al. [55], children after a bidirectional 
cardiopulmonary anastomosis demonstrated only mild forms of arrhythmia early 
postoperatively, most frequently, sinus bradycardia. None of the forms were life-
threatening, and all were transient, and so, in most cases, the children had 
stabilized with a NFSR by the time of discharge. A study by Cohen et al. [56] 
showed similar results. According to their investigations, children who underwent a 
hemi-FO had arrhythmia more frequently at the first day after the operation than 
those who underwent a Glenn operation. However, at discharge, again, there was 
no difference. The Glenn operation includes a transection of the SVC at 5-10 mm 
above the right atrial junction with a closure of the cardiac end of the SVC and a 
connection to the ipsilateral pulmonary artery. In contrast, in the hemi-FO, the 
incision is performed from the superior part of the atrium, close to the sinus node, 
until the medial part of the SVC [56]. Hence, the sinus node and the sinus node 
artery are directly exposed to injury. As the previous hemi-FO facilitates completion 
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with a LT Fontan, these children are then once again exposed to the manipulation of 
the atrium and incisions next to the sinoatrial node, possibly increasing the risk for 
arrhythmia [57].  
Whether the type of second stage operation is a predictor for the onset of 
arrhythmia after FO itself is hard to say, as in our study and in others [56], nearly all 
of the children from the LT group had a hemi-FO as a second stage operation and 
those from the EC group experienced a Glenn operation. However, the onset of 
arrhythmia after FO leads to the assumption that it is the type of FO that provokes 
the occurrence of arrhythmia.  
Furthermore, the type of the first stage operation had no impact on the incidence of 
arrhythmia before FO. After FO, even if not statistically significant, children who 
underwent a Norwood operation with an RV-PA shunt had VES more often than the 
others (P 0.059). However, no increased risk was seen for other forms of 
arrhythmia. Thus, one can assume a RV-PA shunt to be a risk factor for the 
development of arrhythmia, especially VES. The RV-PA shunt as a modification of 
the Norwood operation is known to have hemodynamic advantages, e.g., better 
coronary perfusion, higher diastolic blood pressure, and more balanced systemic-to-
pulmonary flow ratio (Qs:Qp) [58]. Nevertheless, as it is a direct manipulation to the 
ventricle, concerns remain about ventricular function after ventriculotomy, e.g., 
arrhythmia, ventricular dysfunction, or aneurysm formation [59]. Our findings can 
therefore be seen as a consequence of direct ventricular manipulation and 
ventricular dysfunction. However, most of the other studies describe good early and 
late outcome after the Norwood operation with an RV-PA shunt, and no comments 
can be found on the increased risk for arrhythmia [58, 60]. As our results are not 
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statistically significant, we cannot conclude that the RV-PA shunt is a risk factor for 
the development of arrhythmia after FO. 
4.1.2 The Fontan operation as special risk factor for 
arrhythmia 
4.1.2.1 Type of Fontan repair, the surgical procedure itself – LT 
vs EC 
	  
In our investigations, the differences between the two groups of Fontan repair (LT, 
EC) regarding the incidence of arrhythmia in the early period after FO are evident.  
Since the early beginnings of FO, arrhythmia has been one of the feared 
complications. Several studies have described the high risk for the development of 
arrhythmia after FO [22]. In particular, the atriopulmonary connection with its direct 
connection to the atrium was expected to cause arrhythmia difficulties. Gelatt et al. 
identified the atriopulmonary connection as being an independent risk factor for the 
development of atrial tachyarrhythmias [21].  
These results have inspired the development of further alterations of the original FO 
and the bypassing of the atrium with a total cavopulmonary connection. This 
modification was first proposed by de Leval et al. in an in vitro flow modeling study. 
With their new findings, they performed the LT cavopulmonary connection in their 
first 20 patients and demonstrated a reduced risk for early and late arrhythmia [22]. 
The advantage of a total cavopulmonary connection regarding the reduced risk for 
early and late arrhythmia was established in several other studies, e.g., Gardiner et 
al. [61]. 
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Although this variation is advantageous compared with the original atriopulmonary 
FO, it still entails risk factors for arrhythmia. The creation of a LT nevertheless 
causes new surgical scars to the atrium, which might form the morphological basis 
for arrhythmia. This has been demonstrated in an animal study by Gandhi et al. [62]. 
In a canine model, they confirmed that suture lines alone, without atrial hypertension 
or stretch, are able to produce arrhythmia. 
A long suture line, especially next to the crista terminalis, as is necessary in the LT 
technique, might cause atrial re-entry followed by supraventricular tachycardia. 
Even though new techniques aim to avoid the crista terminalis, the presence of 
extensive right atrial trabeculation sometimes makes this impossible. Apart from 
this, during the LT operation, the sinus node itself or its blood supply might be 
damaged by an incision in the top of the atrium, a procedure that is often required to 
enlarge the superior anastomosis. Damage of the sinus node will result in sinus 
node dysfunction and bradyarrhythmia.  
The most recent modification of the FO, namely the EC method, might overcome 
the deficit of the LT cavopulmonary connection. It totally bypasses the atrium and 
therefore avoids any form of surgical intervention in the atrium or the creation of an 
intra-atrial baffle. By totally bypassing the heart and thus reducing the length of the 
atrial suture lines, the EC FO is considered theoretically to be superior to the other 
forms of Fontan completion with regard to the development of arrhythmias. This is 
supported by Amodeo et al. [63] who have demonstrated a 5-year arrhythmia-free 
rate of 92% in an early follow-up report.  
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However, the disconnection of the superior or inferior caval vein from the atrium 
might cause damage to the atrium and therefore the loss of NFSR and development 
of arrhythmia, despite the EC technique. 
	  
The results of our analyses confirm the benefit of an EC Fontain repair technique 
regarding the reduced risk for arrhythmia. During hospitalization, the EC group 
presented with significantly higher numbers of NFSR at all time points. 
Normofrequent junctional ectopic rhythm was significantly more frequent in the LT 
group. JET was only presented by the LT group. However, the incidence of 
postoperative bradycardia did not differ significantly between the two groups. The 
need for a temporary pacemaker after FO was significantly higher in the LT group. 
However, the implantation of a new permanent pacemaker was only required in two 
patients (1 LT and 1 EC). 
	  
Several other studies have confirmed the benefit of the EC modification. Azakie et 
al. describe the reduced risk of early postoperative and mid-term arrhythmia in their 
series of 47 LT vs 60 EC patients [41]. Similar to our results, their LT group had a 
higher risk for supraventricular tachycardia early postoperatively (LT 33%(16) vs EC 
8%(5); P < 0.001) and for junctional rhythm (LT 45%(21) vs 15%(9); P < 0.001). The 
need for a temporary pacemaker was also reduced (LT 32%(15) vs EC 12%(7); P 
0.01). In mid-term follow-up (LT 2.8 ± 1.9 vs EC 2.5 ± 1.4 years), the EC group 
showed less arrhythmia, e.g., sinus node dysfunction, supraventricular tachycardia, 
or need for pacemaking (LT 25% vs EC 7%; P 0.02).  
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Similar results can be seen in the studies of Nürnberg et al. who compared 29 LT vs 
45 EC patients, during an even longer follow-up period (median: LT 7.9 vs EC 4.4) 
[64]. In their study, an early postoperative sinus rhythm was presented more 
frequently in the EC group (LT 50%(13) vs EC 86%(37); P < 0.001). The incidence 
for supraventricular tachyarrhythmia was higher in the LT group (LT 38%(11) vs EC 
11%(5); P < 0.001). Moreover, during follow-up, the EC group presented with less 
arrhythmia than the LT group. 
In a study concerning the postoperative outcome of 200 EC patients, Kim et al. 
describe 85% freedom from arrhythmia after 10 years of follow-up [49]. 
Lee et al. also report reduced sinus node dysfunction among the EC group in the 
postoperative period (LT 22.4% vs EC 11.2%; P 0.05) [65]. 
	  
Although the findings of many investigations support the results of our study,  a few 
have been unable to determine a beneficial effect of the EC modification of Fontan 
repair or have even described a poorer outcome for EC patients with regard to 
arrhythmia. Kumar et al. describe a higher incidence of sinus node dysfunction in 
the EC group early postoperatively (LT 8% vs 27%, P 0.09), at discharge (LT 0% vs 
EC 10%, P 0.02), and during follow-up (LT 15% vs 28%, P 0.2) [66]. Even though, in 
the study of Cohen and colleagues, the EC group was not disadvantaged with 
respect to arrhythmia, they were not able to show a beneficial effect of totally 
bypassing the atrium [56]. Hakacova et al. have presented similar results for both 
groups. They have identified rhythm abnormalities early after Fontan repair in 31 
(52%) EC and 22 (54%) LT patients. Moreover at the 1-year follow-up, the 
prevalence of arrhythmia was similar in LT and EC patients [67].  
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4.1.2.2 Forms of arrhythmia 
	  
The forms of arrhythmia presented within the LT group were mainly of the junctional 
or atrial ectopic rhythm type. Early postoperatively, the LT group had a significantly 
higher incidence of tachycardia without sinus tachycardia (JET, AET) (P <0.001). 
This is similar to SVT. Moreover, normofrequent junctional ectopic rhythm was more 
frequent than in the EC group (P 0.016). Sinus tachycardia and NFSR have 
significantly lower representation than in the EC group (P 0.027, 0.039, 
respectively). In 24h (Holter) ECG analyses, the LT group showed mainly 
normofrequent junctional ectopic rhythm or junctional ectopic bradycardia. At 
discharge, the main part of the group demonstrated normofrequent atrial or juntional 
ectopic rhythm. However, the EC group mainly showed NFSR or sinus bradycardia 
in 24h (Holter) ECG analyses and NFSR or sinus tachycardia at discharge. 
Not only does the LT group show a reduced incidence for NFSR compared with the 
EC group (P 0.039), but also the frequencies for the different forms of arrhythmia 
differ from each other. The arrhythmia forms demonstrated by the EC group are 
mainly sinus tachycardia and sinus bradycardia. In contrast, the arrhythmia forms 
presented within the LT group are mostly junctional ectopic or atrial ectopic rhythms: 
early postoperatively, mainly tachycardia and, at the time of discharge, 
normofrequent. The commonest forms presented by the EC group are physiological 
deviations from NFSR. Sinus tachycardia and sinus bradycardia might be a 
consequence of the new form of circulation and the not yet fully adapted organism. 
Moreover, hypovolemia caused by postoperative chest effusions might provoke the 
incidence of sinus tachycardia. Most cases stabilize during hospitalization so that, at 
discharge, the main part of the group again presents NFSR. On the contrary, the 
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most often presented forms of arrhythmia in the LT group are signs of a sinus node 
dysfunction. This sinus node dysfunction might be explained by a sinus node injury 
or damage of the sinus nodal artery due to surgery. However, not all of these signs 
persist as, at the point of discharge, some of these children have returned to a 
NFSR. Thus, those cases might be explained by a light irritation attributable to 
manipulation during FO. According to these results, we assume that the forms of 
arrhythmia presented by the EC group in the early period after FO are mainly 
physiological and are caused by a missing adaption to the newly achieved Fontan 
circulation. However, the forms of arrhythmia presented by the LT group are mainly 
caused by surgical manipulation and are therefore more severe.  
Similar to our findings, Azakie et al. report higher incidences of sinus node 
dysfunction and SVT, including JET and AET, postoperatively in patients who have 
undergone a LT FO [41]. However, they do not mention a higher frequency of sinus 
bradycardia, possibly because sinus bradycardia is often seen as a sign for sinus 
node dysfunction. Nürnberg et al. have also reported SVT and sinus node 
dysfunction as being the forms of arrhythmia significantly more often represented by 
the LT group [64]. Even if not with the same significant differences, other studies 
have demonstrated the same forms of arrhythmia [21, 56, 68].  
4.1.2.3 Perioperative differences in LT and EC 
	  
The negative influences of CPB, aortal cross-clamping, and cardioplegic cardiac 
arrest on the postoperative outcome after FO are wide spread [69-72]. CPB is a 
known risk factor for postoperative ventricular dysfunction and consecutively 
emerging SVT [73]. Cardioplegia and aortal cross-clamping causing ischemia of the 
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myocardium are especially dangerous for patients with ventricular hypertrophy. 
However, in other cases, cardiac ischemia might also lead to postoperatively 
reduced systolic and diastolic ventricular function with decreased cardiac output and 
elevated end diastolic pressure and an increased risk for arrhythmia. We can 
confirm these experiences with our study results, as patients with NFSR early 
postoperatively had significantly shorter CPB times in our study (P 0.008). In 
particular, those patients who showed junctional ectopic or sinus tachycardia had 
longer CPB times. Patients with aortal cross-clamping during Fontan repair had a 
lower incidence of NFSR at all times (P 0.028).  
Generally, EC FO is known to have a shorter CPB time or is sometimes even 
possible without any CPB at all. In our study, the EC group had significantly shorter 
CPB times (P 0.008). Even though the time of aortal cross-clamping, if necessary, 
did not differ between the two different Fontan repair types, nearly 90% of the EC 
were carried out without aortal cross-clamping. Our findings can significantly confirm 
the negative influence of CPB and aortal cross-clamping on the development of 
postoperatively arrhythmia.  
A conclusion is therefore difficult to make as to whether only the operation technique 
itself, with the various suture lines and forms of manipulation, or the reduced need 
for aortal cross-clamping and the shorter CPB times in the EC group are also 
responsible factors for the lower incidence of arrhythmia in this group.  
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4.1.2.4 Time of onset of arrhythmia and its course 
	  
In patients with Fontan surgery, two time points for the onset of arrhythmia have to 
be distinguished: early after FO or later on, even 2 decades after the repair. 
Early postoperative tachycardia is seen in a small number of patients directly after 
the Fontan repair and, in the majority of cases, is associated with the early 
adaptation to Fontan circulation. The inotropic support used in these situations is an 
independent risk factor for the development of arrhythmia. In this situation, we must 
consider the benefits and risks of such medication and whether it can be 
discontinued (if necessary, a normal rhythm has to be adjusted by pacing). 
Intravenous amiodarone shows a good effect on rhythm control in cases of ectopic 
or juncitional tachycardia [35]. 
Late postoperative tachycardia, e.g., SVT, is mainly presented 6-11 years after FO 
[74]. After the initial appearance of tachycardia, isolated episodes of tachycardia will 
occur. With the passage of time, episodes of tachycardia will become more frequent 
and prolonged with the risk of the development of atrial fibrillation after some years 
[75].  
Symptoms presented by the patients differ with the type of conduction. A 2:1 
conduction with a ventricular frequency of 110-130 beats per minute will cause 
“vague symptoms of unexplained fatigue or respiratory symptoms” [35], whereas a 
rapid 1:1 conduction will bring syncope or even cardiac arrest. 
In both cases, patients with single ventricle physiology are not able to compensate 
for the persistence of tachycardia and may consequently develop massive 
congestive heart failure 12-36 hours after the onset of the heart constantly beating 
faster than 100 bpm.  
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Tachycardia increases the risk of atrial thrombi, which may lead to cerebral (in the 
case of the fenestrated Fontan tunnel) or pulmonary emboli. Therefore, the 
tachycardia must urgently be terminated within 24 hours of onset.  
	  
Even though our study does not include long-term follow-up, a point of interest is 
that the incidence of arrhythmia decreases during the time of hospitalization. 
Compared with the first ECGs after Fontan repair, the ECG analyses at the time of 
discharge show less arrhythmia for patients of both groups. However, the incidence 
of NFSR is still significantly higher in the EC group. The EC group presents with 
nearly the same numbers of NFSR before FO and at discharge, whereas in the LT 
group, only half of the patients regain a NFSR at discharge, compared with the 
number before FO. Similar results have been obtained in other studies [41]. The 
reason for the decrease of arrhythmia during hospitalization might be the rapid 
adaption to the Fontan circulation and the regeneration of the myocardial wounds. 
Because of the inflammatory reaction after operation, the risk for arrhythmia, 
especially tachyarrhythmia, might be increased. In addition to the myocardium itself, 
the adjacent conduction system with its connections might be irritated by the 
surgical procedures in the period directly after FO. However, as they are only 
irritated and not totally destroyed, they are able to recover and revive NFSR. 
Nevertheless, a study by Quinton et al. [76] reports a sudden peak of prevalence in 
arrhythmia at 20-26 years after FO. However, 63% of the study population 
underwent an atriopulmonary (AP) FO and only 24% EC and 13% LT. Another 
important remark is that nearly none of the LT or EC group reached the 
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postoperative span of 20 years in this study. Thus, the peak of sudden arrhythmia 
after 20-26 years is mainly formed by the patients who underwent an AP Fontan.  
With increasing follow-up, the incidence of arrhythmia in patients after FO will 
increase [21, 76], especially in those who manifested early arrhythmia. Hence, they 
should be regularly monitored.  
	  
	  
4.2 Other complications after Fontan repair and 
their triggers 
	  
4.2.1 Adaption to the Fontan circulation 
	  
Azakie et al. reported the longer intubation times for children who underwent a LT 
FO; moreover, the ICU time and hospitalization were longer in this group [41]. For 
patients undergoing an EC procedure, other studies have described shorter 
ventilation times in order to reduce CPB times and avoid cardioplegia [69, 73]. In our 
study, differences with regard to intubation time were not statistically significant. 
However, patients from the EC group tended to have longer intubation times. This 
was the same for children without NFSR early postoperatively. The development of 
arrhythmia after FO had no influence on the ICU time or hospitalization time of the 
children. However, children from the EC group had a significantly longer time of 
hospitalization (P 0.016). This was a remarkable result. Arrhythmia could not have 
been the problem, as it was significantly of lower prevalence in this group. The only 
complication that was significantly higher in children who underwent an EC FO was 
prolonged effusions. Even if the duration of drainage of the total amount of effusion 
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was about the same in both groups, the incidence of developing prolonged effusions 
was higher for the EC group (P 0.038). Moreover, hospitalization for children with 
prolonged effusion was significantly longer than for others (P >0.001). Patients with 
bradycardia in 24h (Holter) ECG had prolonged effusions more often than other 
patients. Moreover, the amount of RP drainage was significantly higher in children 
with sinus bradycardia in 24h (Holter) ECG (P 0.017). However, further significant 
differences in the amount of effusions and bradycardia could not be seen. Other 
investigations have not led to descriptions of a direct correlation between arrhythmia 
and the incidence of prolonged effusions. However, increased pulmonary arterial 
pressure and a reduction of ventricular function are known as risk factors for 
prolonged pleural effusions [50, 73]. In this context, the correlation between 
bradycardia and prolonged effusions in our study might be seen as the physiological 
result of stasis caused by bradycardia and as the limitation of ventricular function 
caused by a lowered heart beat rate. Other studies have also reported prolonged 
effusions attributable to longer CPB time [41]. This correlation cannot be seen in our 
study.  
Interestingly, those patients who underwent the FO without fenestration showed 
more frequent prolonged effusions than those with fenestration (P 0.030). 
Fenestration is known to reduce the incidence of prolonged effusions by lowering 
prepulmonal stasis [22, 73]. Fenestration leads to better ventricular filling and 
maintains cardiac output. Generally, fenestration is propagated to reduce not only 
effusions, but also the time of hospitalization and mortality [26, 28].  
Hence, a possible explanation of the longer hospitalization times in the EC group 
might be the prolonged adaption to the Fontan circulation in those patients. Nearly 
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all of the EC FOs were carried out without fenestration, whereas most of the LT FOs 
included fenestration.  
4.2.2 Thromboembolism 
Generally, all Fontan circulations have a higher risk for thromboembolism because 
of the decelerated systemic venous return. In a study of Rosenthal et al., the 
incidence of thromboembolism was 20%, irrespective of the type of Fontan repair 
[77]. Many studies suggest a higher risk for thromboembolism in patients who later 
undergo FO [78, 79]. In these patients, the atrium is exposed to increased pressure, 
which results from the systemic venous circulation and which leads to turbulences 
and dilation that might cause intra-atrial thombosis followed by thromboembolism. 
Other authors however report that the EC Fontan modification is a risk factor for 
thromboembolism [73, 80]. Limited endothelialization of the artificial material of the 
EC might provoke pulmonary thromboembolism. In our study population, we could 
not find such a complication; however, only massive pulmonary embolism can be 
clinically detected. The LT group shows one case of stroke, which can be a 
consequence of thromboembolism. In our study, almost all children from the LT 
group received fenestration, which can be the route of crossed (paradoxical) 
embolism.  
4.2.3 Bleeding 
Patients who underwent a LT Fontan repair had more frequent bleeding 
complications. Damaging erythrocytes and thrombocytes, the long time needed to 
accomplish the CPB is known to cause bleeding or anemia. Even though all patients 
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in our study were operated on with the CPB, CPB was significantly shorter in 
patients who underwent the EC FO. Sometimes the EC Fontan repair is even 
possible without the use of a CPB [73]. Another important factor can be the 
hypothermia that is used during the LT FO; this can also have deleterious effect on 
the coagulation system and was avoided in all children from the EC group without 
intracardiac procedures. 
 
4.2.4 Medication 
Patients who presented with bradycardia early postoperatively received significantly 
more often dopamine therapy than others. Of those who showed non-sinus 
tachycardia only a few needed amiodarone or adenosine therapy. Thus, one might 
assume that patients with bradycardia have a special need for anti-arrhythmic 
medication. However, other forms of arrhythmia are often treated with temporary 
pacemaking (see below). Nonetheless, in our study, the need for anti-arrhytmic 
medication after FO was rare, and no difference was seen regarding the need for 
anti-arrhythmic medication between the two groups of Fontan repair. Contrary to 
these findings, Nürnberg et al. described a higher rate of postoperative need for 
anti-arrhythmic medication in children who underwent the LT FO [64]. 
A significant correlation was found between the incidence of arrhythmia early 
postoperatively and catecholamine therapy, especially adrenaline therapy. Children 
who showed no NFSR early postoperatively after FO received significantly more 
often catecholamine therapy. In particular, those having adrenaline therapy 
presented significantly more often with sinus tachycardia or non-sinus tachycardia. 
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The children who received glycoside therapy showed sinus tachycardia significantly 
more often than others. Catecholamines, e.g., adrenaline, are used to stabilize the 
cardiac output in children with low blood pressure. Glycosides are also used in 
children with low cardiac pump function. Even if not reported by other colleagues, 
such medication is generally known to cause arrhythmia as a negative side effect. 
Hence, the high frequencies of tachycardia, especially sinus tachycardia, can also 
be explained by the need for this medication in the first few days after FO.  
	  
4.2.5 Pacemaking 
The need for temporary pacemaking after FO was significantly higher in the LT 
group (P <0.001). The main reason for temporary pacemaking was the junctional 
ectopic rhythm. Similar results were presented by Azakie et al. [41]. With regard to 
the new implantation of a permanent pacemaker during hospitalization after FO, no 
significant difference was found between the two groups (LT, EC). In the patients of 
the study by Nürnberg et al., the need for temporary pacemaking was significantly 
higher in the group of children who underwent LT FO. Permanent pacemaker 
implantation during mid- and long-term follow-up was only necessary in patients 
from the LT group [64]. In the study of Kumar et al., arrhythmia and the need for 
new permanent pacemaker implantation during hospitalization after FO was more 
frequent in the EC group; however, the authors did not mention new pacemaker 
implantation during follow-up [66]. Cohen et al. report the rare need for pacemaking 
after FO. New permanent pacemaker implantation was only necessary in one of LT 
patients.  
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4.3 Conclusions 
	  
 
Patients who underwent EC FO demonstrated significantly more often NFSR in the 
early postoperative period. Normofrequent junctional ectopic rhythm and junctional 
tachycardia was significantly more frequent in the LT FO group (early 
postoperatively and at discharge). JET was only manifested by the LT group, and 
the need for temporary pacemaking, above all reasons, was significantly higher in 
the LT group.  
In the long-term follow-up after second stage procedure directly before FO, no 
significant differences were seen between the children after bidirectional Glenn 
anastomosis and hemi-FO with regard to the incidence of the various forms of 
arrhythmia. 
Longer CPB time and the use of aortal cross-clamping had a negative effect on the 
cardiac rhythm postoperatively. Patients without NFSR in the early postoperative 
period had significantly longer CPB times and were operated upon more often with 
cardioplegic cardiac arrest. 
The presence of fenestration in the Fontan circulation facilitates the early 
postoperative adaptation to the passive pulmonary blood flow. Children without 
fenestration stayed longer in the hospital and more often presented prolonged 
effusions. 
Children at the age of 2 to 4 years at the time of FO presented a trend toward lower 
incidence of all forms of arrhythmia in the early postoperative period. 
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4.4 Limitations of the study 
 
 
 
The design of the study was retrospective. The selection for the type of FO was 
given by the previous second stage operation. Nearly all LT FO previously 
underwent a hemi-Fontan operation and nearly all EC FO a Glenn operation. 
However the final decision to perform either a LT or an EC FO was made by the 
surgeon himself. This causes a certain bias to the study. A double-blinded study 
design could give more plausible results.  
A single person has retrospectively analyzed the ECG diagnostic. Most of the data 
have been collected from patient files and have been retrospectively analyzed.  
The number of patients (169) included in this study is generally seen as being 
suitable for statistically significant analyses. However, the two groups (LT, EC) were 
of different sizes (LT 56, EC 113). Moreover, the spectrum of the cardiac anomalies 
differed between the two groups. HLHS, which not in our but in other studies forms 
a risk factor for arrhythmia, was overrepresented in the LT group.   
Fenestration, which had a positive influence on the duration of hospitalization, was 
only performed in the LT group.  
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5.2 List of abbriviations 
 
AAI atrium-atrium-inhibition 
ACE angiotensin converting enzyme 
AET atrial ectopic tachycardia  
AF atrial fibrillation  
AFL atrial flutter 
Ao aorta 
APC atriopulmonary connection 
ASA acetylsalicylic acid 
Asc ascendens 
AV atrioventricular 
AVNRT atrioventricular nodal reentrant tachycardia 
BT Blalock-Taussig 
bpm beats per minute 
CAVC common atrioventricular canal 
CHD congenital heart disease 
cm centimeters 
CPB cardiopulmonary bypass 
CV common ventricle 
d days 
DILV double inlet left ventricle 
DOLV double outlet left ventricle 
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DORV double outlet right ventricle 
DP diastolic pressure 
d-TGA d-transposition of the great arteries 
EC extracardiac conduit 
ECG electrocardiogram 
ECHO echocardiography 
ECMO extracorporeal membrane oxygenation  
EDP end diastolic pressure 
ePTFE expanded polytetrafluoroethylene 
FO Fontan operation 
FU follow up 
h hours 
HLHS hypoplastic left heart syndrome 
HRHS hypoplastic right heart syndrome 
ICU intensive care unit 
Ix index 
JET junctional ectopic tachycardia 
kg kilogramms 
LA left atrium 
LP left pleura 
LPA left pulmonary artery 
LT lateral tunnel 
MAPCA major aortopulmonary collateral artery 
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m months 
ml milliliters 
mm millimeters 
MP mean pressure 
MWU Mann Whitney U test 
NFQ normofrequent  
NFSR normofrequent sinus rhythm 
OP operation 
PA pulmonary artery 
pO2 partial oxygen pressure 
PTFE polytetrafluoroethylene 
PVR pulmonary vascular resistance 
Qp:Qs pulmonary-to-systemic flow ratio 
QRS QRS complex 
RA right atrium 
RP right pleura 
RPA right pulmonary artery 
RU resistance unit = Wood unit 
RV-PA right ventricle-pulmonary artery 
SA sinoatrial 
SANTR sinoatrial node reentrant tachycardia  
Sat saturation 
SD standard deviation  
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SL single left 
SP systolic pressure 
SR single right 
ST sinus tachycardia 
SV single ventricle  
SVC superior vena cava 
SVT supraventricular tachycardia 
SVR systemic vascular resistance 
TA tricuspid atresia 
TCPC total cavopulmonary connection 
TGA transposition of the great arteries 
VCI vena cava inferior 
VCS vena cava superior 
VES ventricular extrasystoles 
VSD ventricular septal defect 
VT ventricular tachycardia 
y years 
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6 Abstract 
The Fontan operation (FO) allows to separat the blood circulation in children with a 
univentricular heart. It thereby establishes two circulations, which are placed in 
series: a passive pulmonary and an active systemic circulation. This new gained 
circulation system allows a good survival of the children with a nearly normal 
upgrowth. 
The first so-called FO was performed in 1968 [17], although this had taken a long 
time to be achived. Many surgeons were involved in the process of establishing this 
method [2, 4-8].  Today, mainly two modifications of FO are performed: the lateral 
tunnel (LT FO), which connects the inferior vena cava to the pulmonary artery by a 
tunnel in the lateral atrium, and the extracardiac conduit (EC FO), which connects 
the vena cava inferior to the confluent pulmonary artery system. Because of less 
manipulation, shorter atrial suture lines, and constant low intra-atrial pressure, the 
EC FO is supposed to cause less arrhythmia.   
 
The aim of our study was to analyze whether the type of Fontan repair has an 
influence on the incidence of arrhythmia and whether one procedure is superior to 
the other regarding the postoperative outcome. 
 
169 children constituted the study population. 56 (33.1%) children underwent a LT 
Fontan procedure and 113 (66.9%) an EC FO. Most of them had single right 
ventricle anatomy (66.3% SR – LT 82.1 vs EC 58.4%). Depending on the 
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hemodynamic type, all children had at least one palliative operation before FO. 
Nearly all of the EC patients had undergone a bidirectional Glenn operation 
beforehand, and nearly all of the LT patients had had a hemi-FO. The final FO was 
performed by a single surgical team in a single institute (Pediatric Cardiac Surgery, 
Klinikum Großhadern, Ludwig Maximilian University, Munich).  The patient data was 
analyzed retrospectively. 
 
In our study, FO had a significant influence on the development of arrhythmia. 
Patients who underwent EC FO had significantly more NFSR in the early period 
after FO (early postoperatively - LT 15% vs EC 30.2%, P 0.039, 24h ECG (Holter) 
during hospitalization - LT 30% vs EC 58%, P 0.030, at discharge - LT 36.5% vs EC 
56%, P 0.020). Normofrequent junctional ectopic rhythm was significantly more 
frequent in the LT group (early postoperatively - LT 20.8% vs EC 7.5%, P 0.016, at 
discharge - LT 17.3% vs 1.0%, P <0.001). JET was only presented by the LT group 
(LT 18.9% vs EC 0%, P < 0.001). Moreover, the need for temporary pacemaking 
was significantly higher in the LT group (P <0.001). 
In addition to the type of Fontan repair, CPB time and the use of aortal cross-
clamping had a negative effect on the development of arrhythmia postoperatively. 
Patients without NFSR in the early postoperative period had significantly longer 
CPB times (P 0.008), and those who were operated upon without aoral cross-
clamping showed significantly more NFSR (P 0.027). Patients from the EC group 
had significantly shorter CPB times (P 0.004) and less need for aortal cross-
clamping.  
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The time of adaption to the total passive pulmonary blood flow and therefore the 
time of hospitalization (P 0.016) was longer in the EC group. Children who 
underwent an EC FO had a higher incidence of prolonged effusions (P 0.038). 
However, we see this as based not on the EC Fontan repair itself, but on the lack of 
fenestration in this group. LT FO included significantly more often fenestration (P 
<0.001). Patients who underwent fenestration had a lower incidence of prolonged 
effusions (P 0.030) and, therefore, shorter times of hospitalization (P <0.001). 
 
According to the results of our study, we assume that EC FO outmatches LT with 
respect to the postoperative outcome, especially regarding the early development of 
arrhythmia. 
Besides, the fact, that both procedures were performed during the same periode of 
time by one surgical team in a single institute, provides a special initial situation for 
analyses.   
Nevertheless, we have only observed the early period after FO, and we have to 
await the passage of time to be able to make statements regarding mid- and long-
term follow-ups. However, other studies with similar results of early outcome allow 
estimations suggesting that the EC group will still show advantages in the near 
future.  
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7 Zusammenfassung 
Die Fontan Operation ermöglicht die Trennung der Blutkreisläufe bei Kindern mit 
univentrikulärem Herzen. Hierbei werden zwei separate Kreisläufe geschaffen, die 
in Serie zueinander geschaltet sind: ein passiver pulmonaler und ein aktiver 
systemischer Kreislauf. Dank dieser neuen Kreislaufsituation wird den Kindern ein 
Überleben mit nahezu normaler Entwicklung ermöglicht. 
Die erste sogenannte Fontan Operation wurde 1968 durchgeführt [17]. Die 
Etabilierung dieser Methode dauerte jedoch einige Jahre. Viele verschiedene 
Chirurgen waren an der Entwicklung dieser OP Technik beteiligt [2, 4-8]. Heute 
finden hauptsächlich zwei Varianten der Fontan Operation Anwendung. Das 
Laterale Tunnel (LT), welches die untere Vena cava mit der Pulmonalarterie über 
einen Tunnel im lateralen Vorhof verbindet, und das Extracardiale Conduit (EC), 
welches die Vena cava inferior mit dem konfluenten pulmonlarteriellem System 
zusammenführt. Die extrakardiale Variante soll auf Grund von geringerer 
Manipulation und kleineren Nähten im Vorhof sowie konstant niedrigen intraatrialen 
Drücken weniger Arrhythmien verursachen. 
 
Mit unserer Studie wollten wir den Einfluss der Fontan OP auf die Entstehung von 
Arrhythmien, sowie die mögliche Überlegenheit einer der beiden Varianten auf das 
postoperative Ergebnis untersuchen. 
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Die Studiengruppe fasste 169 Kinder. 56 (33.1%) der Kinder erhielten eine laterale 
Tunnel Operation und 113 (66.9%) eine Operation mittels Extracardialem Conduit. 
Der Großteil der Kinder hatte eine Rechtsherztyp Anatomie (66.3% SR – LT 82.1 vs 
EC 58.4%).  Abhängig vom hämodynamischen Typ erhielten alle Kinder vorab 
zumindest eine weitere palliative Operation vor der Fontan Operation. Fast alle der 
EC Patienten hatten eine bidirektionale Glenn Operation und fast alle der LT 
Patienten eine hemi-Fontan Operation. Die finale Fontan Operation wurde stets von 
ein und demselben chirurgischen Team in einem einzigen Krankenhaus 
durchgeführt (Herzchirurgische Kinderklink, Klinikum Großhadern, Ludwig 
Maximilians Universität, München). Die Datenanalyse erfolgte retrospektiv. 
 
In unserer Studie hatte die FO einen signifikanten Einfluss auf die Entwicklung von 
Herzrhythmusstörungen. Patienten, die mittels EC FO versorgt wurden, hatten in 
der frühen postoperativen Phase nach Fontan OP signifikant häufiger einen 
normofrequenten Sinusrhythmus (früh postoperativ - LT 15% vs EC 30.2%, P 0.039, 
24h EKG während des stationären Aufenthalts - LT 30% vs EC 58%, P 0.030, bei 
Entlassung - LT 36.5% vs EC 56%, P 0.020). Ein normofrequenter junctionaler 
ektopischer Rhythmus fand sich signifikant häufiger in der LT Gruppe (früh 
postoperativ - LT 20.8% vs EC 7.5%, P 0.016, bei Entlassung - LT 17.3% vs 1.0%, 
P <0.001). Junktionale ektopische Tachykardien zeigten sich lediglich in der LT 
Gruppe (LT 18.9% vs EC 0%, P < 0.001). Auch ein temporärer Schrittmacher wurde 
signifikant häufiger in der LT Gruppe benötigt (P <0.001). 
Neben der Fontan OP Variante hatte die kardiopulmonale Bypasszeit und die 
Verwendung eines Aortencrossclampings einen negativen Effekt auf die 
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Entwicklung postoperativer Rhythmusstörungen. Patienten ohne normofrequenten 
Sinusrhythmus in der frühen postoperativen Phase hatten signifikant längere 
kardiopulmonale Bypasszeiten während der OP gehabt (P 0.008). Patienten, die 
ohne Crossclamping operiert wurden, hatten signifikant häufiger einen 
normofrequenten Sinusrhythmus (P 0.027). Patienten der EC Gruppe hatten 
signifikant kürzere CPB Zeiten (P 0.004) und weniger häufig Anwendung eines 
Crossclampings. 
 
Anzumerken ist, dass die Gewöhnung an den neuen Kreislauf und der damit 
verbundene stationäre Aufenthalt nach der OP in der EC Gruppe singnifikant länger 
dauerte (P 0.016). Kinder, bei denen eine extracardiale Fontan Operation 
durchgeführt wurde, hatten eine höhere Inzidenz an verlängerter Ergussbildung 
postoperativ (P 0.038). Dennoch sehen wir den Grund hierfür nicht bei dem 
extracardialen Vorgehen selbst, sondern bei der fehlenden Fenestration. Die LT FO 
war signifikant häufiger mit einer Fenestrierung kombiniert durchgeführt worden (P 
<0.001). Patienten die eine Fenestration erhielten, hatten eine niedrigere Inzidenz 
für verlängerte Ergussbildung (P 0.030) und somit kürzere Hospitationszeiten (P 
<0.001).  
 
Anhand der Ergebnisse unserer Studie sehen wir die extracardiale Fontan 
Operation dem lateralen Tunnel gegenüber überlegen was das postoperative 
Ergebnis und die Entwicklung von Herzrhythmusstörungen angeht.  
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Die Tatsache, dass beide Operationsvarianten zur gleichen Zeit an ein und dem 
selben Institut durch ein idenentisches chirurgisches Team praktiziert wurden, stellt 
eine besondere Ausgangssitutation für die Auswertung dar. 
Bislang haben wir nur die frühe postoperative Periode nach der Fontan Operation 
analysiert und es dauert noch, bis Aussagen bezüglich der Langzeitverläufe 
gemacht werden können. Jedoch erlauben andere Studien mit ähnlichen 
Ergebnissen in der frühen postoperativen Phase Vermutungen anzustellen, dass 
auch im Langzeitverlauf die EC FO die überlegene Operationsvariante darstellt. 
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